Digging Deeper with Diffuse Correlation Spectroscopy by Verdecchia, Kyle J
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
7-25-2016 12:00 AM 
Digging Deeper with Diffuse Correlation Spectroscopy 
Kyle J. Verdecchia 
The University of Western Ontario 
Supervisor 
Dr. Keith St. Lawrence 
The University of Western Ontario 
Graduate Program in Medical Biophysics 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Kyle J. Verdecchia 2016 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Medical Biophysics Commons, and the Optics Commons 
Recommended Citation 
Verdecchia, Kyle J., "Digging Deeper with Diffuse Correlation Spectroscopy" (2016). Electronic Thesis and 
Dissertation Repository. 3930. 
https://ir.lib.uwo.ca/etd/3930 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
Abstract 
Patients with neurological diseases are vulnerable to cerebral ischemia, which can lead to 
brain injury. In the intensive care unit (ICU), neuromonitoring techniques that can detect 
flow reductions would enable timely administration of therapies aimed at restoring adequate 
cerebral perfusion, thereby avoiding damage to the brain. However, suitable bedside 
neuromonitoring methods sensitive to changes of blood flow and/or oxygen metabolism have 
yet to be established. 
Near-infrared spectroscopy (NIRS) is a promising technique capable of non-
invasively monitoring flow and oxygenation. Specifically, diffuse correlation spectroscopy 
(DCS) and time-resolved (TR) NIRS can be used to monitor blood flow and tissue 
oxygenation, respectively, and combined to measuring oxidative metabolism. The work 
presented in this thesis focused on advancing a DCS/TR-NIRS hybrid system for acquiring 
these physiological measurements at the bedside. 
The application of NIRS for neuromonitoring is favourable in the neonatal ICU since 
the relatively thin scalp and skull of infants has minimal effect on the detected optical signal. 
Considering this application, the validation of a combined DCS/NIRS method for measuring 
the cerebral metabolic rate of oxygen (CMRO2) was investigated in Chapter 2. Although 
perfusion changes measured by DCS have been confirmed by various flow modalities, 
characterization of photon scattering in the brain is not clearly understood. Chapter 3 presents 
the first DCS study conducted directly on exposed cortex to confirm that the Brownian 
motion model is the best flow model for characterizing the DCS signal. Furthermore, a 
primary limitation of DCS is signal contamination from extracerebral tissues in the adult 
head, causing CBF to be underestimated. In Chapter 4, a multi-layered model was 
implemented to separate signal contributions from scalp and brain; derived CBF changes 
were compared to computed tomography perfusion. 
 Overall, this thesis advances DCS techniques by (i) quantifying cerebral oxygen 
metabolism, (ii) confirming the more appropriate flow model for analyzing DCS data and 
(iii) demonstrating the ability of DCS to measure CBF accurately despite the presence of a 
thick (1-cm) extracerebral layer. Ultimately, the work completed in this thesis should help 
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with the development of a hybrid DCS/NIRS system suitable for monitoring cerebral 
hemodynamics and energy metabolism in critical-ill patients. 
Keywords 
Near-Infrared Spectroscopy, Diffuse Correlation Spectroscopy, Delayed Cerebral Ischemia, 
Cerebral Blood Flow, Cerebral Oxidative Metabolism. 
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Chapter 1  
1 Introduction 
The intention of this introductory chapter is to give a rationale for the experiments that 
comprise this thesis entitled: “Digging Deeper with Diffuse Correlation Spectroscopy”. 
First, the clinical rationale for developing a non-invasive device to monitor cerebral 
hemodynamics in patients in the intensive care unit (ICU) is presented. A description of 
current clinical methodologies and their limitations are outlined. This is followed by a 
description of a promising optical technique that may overcome some of the caveats of 
current methods. The theoretical basis of this optical technique, known as diffuse 
correlation spectroscopy (DCS), is provided, and followed by an extensive review of 
current applications and limitations of this technology. 
1.1 Clinical Rationale 
1.1.1 Intensive Care Patients 
In 1953, during the polio epidemic, hundreds of patients developed respiratory failure, 
requiring emergency tracheotomies. However, typical hospitals at that time had 
inadequate resources to accommodate the patient overload. As a result, the first ICU was 
established to perform tracheotomies quickly, ultimately reducing mortality (Kelly, Fong, 
C, & D, 2014). Generally, an ICU describes a location where critically ill patients obtain 
proper care from specialists. Over the past twenty years, the ICU has evolved into 
multiple sub-specialty treatment centers, such as the neonatal and neurological ICUs, that 
cater towards a particular disease or complication, with the aims of improving patient 
outcome and reducing mortality. 
 Common to both neonatal and neurological ICUs is the concern for maintaining 
adequate cerebral blood flow (CBF). Preterm infants make-up a large portion of patients 
in the neonatal ICU and their immature cerebral vasculature makes them susceptible to 
impaired autoregulation of CBF (Peeples, Mehic, Mourad, & Juul, 2015). Within the 
neurological ICU, patients who have experienced a neurological emergency, such as a 
stroke (Aries, Elting, De Keyser, Kremer, & Vroomen, 2010), a subarachnoid 
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hemorrhage (SAH) (Otite et al., 2014; Washington & Zipfel, 2011), or a traumatic brain 
injury (TBI) (Bouma & Muizelaar, 1992; White & Venkatesh, 2008), are vulnerable to 
further complications, including cerebral edema, cerebral vasospasm, and impaired 
cerebral autoregulation. 
1.1.2 Neurological Complications 
In patients requiring intensive care due to one of the various neurological emergencies 
mentioned earlier, further complications often cause elevated intracranial pressure (ICP) 
and a corresponding decrease in CBF. Therefore, the goal of current interventions that 
target ICP is ultimately to increase CBF. 
A primary concern with ICU patients is cerebral edema, which refers to the 
accumulation of excessive fluid in the brain. For instance, mortality for patients with 
large hemispheric strokes who have evidence of cerebral edema is up to 80% (Hacke et 
al., 1996; Ropper, 1984). Cerebral edema leads to elevated ICP due to volume constraints 
within the cranium. In turn, elevated ICP can impair CBF by reducing cerebral perfusion 
pressure (CPP), making patients susceptible to secondary ischemic brain injury. 
Management techniques to reduce ICP include the administration of hyperosmolar 
agents, such as mannitol or hypertonic saline, to promote osmotic flow outward from 
brain parenchyma (Singh & Edwards, 2013). Should a poor response be observed, more 
aggressive approaches, such as spinal taps and external ventricular drain (EVD) or 
decompressive craniectomy, are performed to drain excessive fluid or increase the 
volume capacity of the brain, respectively, both of which reduce ICP in order to restore 
cerebral perfusion. 
Another cause of delayed cerebral ischemia (DCI), which occurs in approximately 
60% of SAH patients, is cerebral vasospasm, which is caused by involuntary constriction 
of arteries in the brain (Weir, Grace, Hansen, & Rothberg, 1978). Between 20-50% of 
SAH patients develop secondary cerebral ischemia (Schmidt et al., 2008), which may 
progress into infarcted cerebral tissue. Symptoms of clinical deterioration and newly 
formed infarcts trigger the use of interventional strategies, such as administrating the 
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vasodilator nimodipine (Macdonald, 2014); however, about one-third develop infarction 
due to vasospasm asymptomatically (Schmidt et al., 2008). 
The maintenance of CBF over a wide range of systemic blood pressure is 
described by cerebral autoregulation (CA). During variations in blood pressure (Figure 
1-1), normal CBF is maintained (~50 mL/100g/min) by adjustments to cerebrovascular 
resistance (Steiner & Andrews, 2006). However, impairment to CA occurs in about one-
third of patients with TBI (Bouma, Muizelaar, Bandoh, & Marmarou, 1992; Muizelaar, 
Ward, Marmarou, Newlon, & Wachi, 1989), leaving patients susceptible to CBF 
fluctuations during spontaneous changes in systemic blood pressure (Robertson et al., 
1999), and ultimately, these patients are vulnerable to DCI. Similar therapeutic 
interventions to those mentioned earlier (i.e. surgical intervention, or administering 
hyperosmolar and/or vasodilating drugs) are employed to increase CBF. 
 
Figure 1-1: Cerebral Autoregulation Plateau; adapted from (White & Venkatesh, 
2008) 
1.1.3 Clinical Management 
Currently, there is no standard method of diagnosing DCI (Sanelli et al., 2014). The best 
predictor of negative outcome for ICU patients depends on neurological examinations of 
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their physical characteristics (Alonso et al., 2015; De Oliveira Manoel et al., 2015; 
English et al., 2013; Kirkman, Citerio, & Smith, 2014), such as level of consciousness as 
assessed by the Glasgow Coma Scale (Picciolini et al., 2015; Tyson, Parikh, Langer, 
Green, & Higgins, 2008). Clinical classification scales can help identify patients who are 
vulnerable to DCI, but they lack specificity and sensitivity (Vergouwen et al., 2010). 
Patient management would be strengthened by monitoring tools that could detect early, 
subtle, functional changes, such as impaired CA (De Oliveira Manoel et al., 2015). 
Furthermore, management of stroke patients has been shown to improve outcome and 
decrease mortality (Alonso et al., 2015; P. Langhorne et al., 2005) and is especially 
important during the early-onset of cerebral edema, which peaks a few days after 
infarction (Shaw, Alvord, & Berry, 1959). However, to diagnose the susceptibility of 
DCI in patients that are heavily sedated or comatose is not appropriate (Vergouwen et al., 
2010). A continuous bedside assessment of the neurological deterioration would improve 
sensitivity for early detection and prevention of DCI. 
In general, an ICU with specialized neurointensivists results in better efficiency 
and earlier discharge due to improved patient outcome (Bershad, Feen, Hernandez, Suri, 
& Suarez, 2008; Diringer & Edwards, 2001; Unit & Collaboration, 2013). Providing the 
specialized neurointensivists with proper tools for monitoring neurological deterioration 
can further improve patient outcome by aiding in early detection of DCI (Sarrafzadeh, 
Vajkoczy, Bijlenga, & Schaller, 2014). One approach for detecting DCI is by measuring 
CPP, which is defined as the difference between the mean arterial pressure (MAP) and 
ICP. When possible, current clinical management techniques detect low perfusion by 
monitoring a surrogate physiological parameter of perfusion, ICP, since common 
neurological complications result from elevated ICP. In adults, ICP is normally between 
7-15 mmHg, with pressures greater than 20 mmHg considered neurologically significant 
(Bratton et al., 2007). This would enable the intensivist team to determine if CBF falls to 
ischemic levels, which is typically defined as values below 15 mL/100g/min (Symon, 
Branston, Strong, & Hope, 1977). However, specific pressure thresholds presented in the 
literature have been inconsistent (Steiner & Andrews, 2006), suggesting that a method of 
directly measuring CBF would assist in the management of neurological emergencies. 
Early detection of low blood flow would provide the opportunity to administer 
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therapeutic treatments to restore CBF in order to prevent secondary brain injury (Coles et 
al., 2002; Surgeons., 2007). 
In addition to monitoring CBF, measuring the cerebral metabolic rate of oxygen 
(CMRO2) could help identify clinically significant blood flow reductions, i.e. decreases 
that exceed the compensatory increase in oxygen extraction. This is demonstrated in 
Figure 1-2, which shows the reduction in CMRO2 that occurs when the increase in the 
oxygen extraction fraction (OEF) is not sufficient to match the drop in CBF (Dhar et al., 
2012; Powers, Grubb, Darriet, & Raichle, 1985; Vespa et al., 2005). For example, in 
SAH patients, DCI is directly related to poor outcome (Vergouwen, Ilodigwe, & 
MacDonald, 2011); however, cerebral infarction can occur without any observable 
symptoms during normal pressure levels (Chen et al., 2011; Schmidt et al., 2008). 
Insufficient oxygen delivery to brain tissue results in failing ion pumps and deficiencies 
of energy required for cell survival (Boas & Franceschini, 2011; Powers et al., 1985). 
However, there is no ideal monitoring device of perfusion/metabolism at the bedside (Le 
Roux, 2013). 
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Figure 1-2: Stages of hemodynamic impairment as cerebral tissue perfusion fails; adapted 
from (Dhar & Diringer, 2016) 
1.2 Neuromonitoring Methods 
1.2.1 Invasive Techniques 
An important aspect of intensive care practice is monitoring ICP, which requires inserting 
an invasive fiberoptic probe into the brain parenchyma or a catheter into the 
intraventricular space. Elevated ICP is associated with the incidence of secondary 
ischemic brain injury as well as worse clinical outcome (Andrews et al., 2002; Juul, 
Morris, Marshall, & Marshall, 2000). Therefore, increased ICP indicates to a 
neurointensivist to administer therapeutics designed to improve CBF; however, 
observational studies question the benefits of monitoring ICP (Cremer et al., 2005; Shafi, 
Diaz-Arrastia, Madden, & Gentilello, 2008). It could be argued that this is not 
unexpected since ICP is only a surrogate marker of perfusion and that variations in 
cerebral vascular resistance could alter the relationship between the two. 
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Rather than monitoring ICP, cerebral perfusion can be measured by inserting laser 
Doppler flowmetry (LDF) or thermal diffusion flowmetry (TDF) probes directly into 
brain parenchyma. The former is a well established technique for real-time flow 
monitoring; however, it only measures relative flow changes. Although technically 
challenging, TDF provides quantitative measurements of local cerebral perfusion and has 
been shown to detect CBF changes associated with vasospasm (Vajkoczy, Horn, Thome, 
Munch, & Schmiedek, 2003). 
 In addition to flow monitoring, cerebral microdialysis (CMD) probes provide the 
capability to measure the biochemistry of tissue (Tisdall & Smith, 2006). In particular, an 
increase in the lactate/pyruvate ratio (LPR) has proven to be a reliable biomarker of tissue 
ischemia (Ståhl, Mellergård, Hallström, Ungerstedt, & Nordström, 2001). Also, brain 
tissue oxygen tension (PbtO2) can be measured by a Clark electrode. In TBI and SAH 
patients, PbtO2 monitoring has been shown to improve outcome compared to 
management based on ICP monitoring (Narotam, Morrison, & Nathoo, 2009; 
Ramakrishna et al., 2008). However, in an ischemic stroke population, approximately 
half of the patients who were treated for elevated ICP showed changes in the jugular 
venous oxygen saturation that did not reflect concurrent CBF measurements (i.e. 
oxygenation remained unchanged when CBF was altered, and vice versa), despite finding 
reductions of both parameters in non-survivors (Keller, Steiner, Fandino, Schwab, & 
Hacke, 2002). This suggests that monitoring jugular bulb oximetry alone should be 
interpreted with caution and highlights the importance of supplementing oxygenation 
values with a direct measurement of CBF to determine the efficacy of therapeutic 
treatments. 
Despite the ability of each technique to monitor a key physiological parameter at 
the bedside, all such devices are highly invasive since they require inserting a probe 
directly into the tissue. Invasive probes/catheters increase the risk of hemorrhage and 
ventriculitis (Narayan et al., 1982; Pfausler et al., 2004); the latter is susceptible to higher 
risk from repetitive catheter insertions (Arabi et al., 2005). Furthermore, these invasive 
techniques are limited to assessing a small tissue volume (~1 mm3) near the location of 
the probe. Due to their invasive nature, the use of these methods is typically restricted to 
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severe brain-injured patients. Nevertheless, the sensitivity of these methods to impaired 
CBF and energy metabolism highlights the potential value that non-invasive monitoring 
methods could provide to neuro-intensive care.  
1.2.2 Transcranial Doppler Sonography 
A non-invasive technique, known as transcranial Doppler (TCD), has proven to be 
valuable for diagnosing and monitoring cerebral vasospasm (Sekhar, Wechsler, Yonas, 
Luyckx, & Obrist, 1988), a known precursor to secondary brain injury in SAH patients 
(Connolly et al., 2012; Staalsø, Edsen, Romner, & Olsen, 2013). Principally, TCD is used 
to measure flow velocities in the middle cerebral artery (MCA) (Sloan et al., 2004; 
Washington & Zipfel, 2011), which supplies ~80% of hemispheric blood flow (Moore, 
David, Chase, Arnold, & Fink, 2006). In the MCA, vasospasms are identified by TCD 
with a high specificity (94-100%) but moderate sensitivity (38-91%), and its application 
to other cerebral arteries has proven less accurate (Lee et al., 2006; Washington & Zipfel, 
2011). Arterial blood flow velocities are related to perfusion in the macro-vasculature, 
and therefore, TCD velocity measurements do not reflect micro-vascular perfusion. This 
suggests a means to directly measure CBF would be beneficial, especially for detecting 
and monitoring secondary cerebral ischemia, since presence of vasospasms does not 
solely contribute to cerebral infarction and neurological worsening (Vergouwen et al., 
2011). 
1.3 Near-Infrared Spectroscopy 
The work completed in this dissertation is driven by the current lack of a means of 
measuring CBF in the clinic that is both non-invasive and direct; one promising 
technique is near-infrared spectroscopy (NIRS). Because of its low absorption in tissue, 
electromagnetic radiation within the near-infrared wavelength spectrum (700-1000 nm) 
can travel farther than visible light. Consequently, this wavelength range is often referred 
to as an “optical window” (Jöbsis, 1977). The interaction of electromagnetic radiation 
with tissue is governed by two fundamental interactions: absorption and scattering, which 
are described in the following sections.  
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1.3.1 Electromagnetic Radiation 
Electromagnetic radiation can be classified as either ionizing or non-ionizing depending 
on how energy is transferred to the surrounding medium. The former carries sufficient 
energy per quantum to liberate an electron from an atom or molecule, e.g. x-rays. Near-
infrared light is classified as the latter since it does not have sufficient energy to liberate 
an electron. Instead, energy is transferred non-destructively to an absorbing molecule in 
tissue by excitation of a vibrational state through a quantum event (i.e. all or nothing). If 
the frequency of a photon equals the energy required for a molecule to transition to an 
excited state, then the photon is absorbed, otherwise, a photon is re-emitted (i.e. 
scattered). 
The interactions incurred by a photon as it propagates through a medium is 
characterized by the scattering (µs) and absorption (µa) coefficients, which represent the 
reciprocal of typical distances traveled before a photon is either scattered or absorbed. 
These interactions may alter one or more of a photon’s characteristics: energy, phase, 
polarization, and direction, as described in the following sections. 
1.3.2 Photon Absorption 
In the 1700s, the mathematician Pierre Bouguer was the first to arithmetically describe 
light absorption in a non-scattering medium. He discovered that the intensity of 
transmitted light (I) is related exponentially to µa and the distance between source and 
detector (ρ) in a homogeneous medium:  
I = Ie     (1.3.1) 
where I0 represents the source light intensity. In 1852, August Beer observed that light 
absorption was proportional to the concentration (ci) of a light-absorbing molecule in the 
medium, which is referred to as chromophore. In the presence of multiple chromophores, 
the absorption coefficient can be written as: 
μ
λ = ln10∑ ελc    (1.3.2) 
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where ε is the wavelength-dependent extinction coefficient of chromophore i. In tissue, 
the main absorbing chromophores of near-infrared (NIR) light are oxyhemoglobin, 
deoxyhemoglobin, water, and lipid. The wavelength-dependency of absorption 
characteristics are illustrated in Figure 1-3. 
 
Figure 1-3: Absorption coefficients of the main chromophores in tissue plotted as a 
function of wavelength; data adapted from Oregon Medical Laser Clinic 2013 
Figure 1-3 highlights that the dominant tissue chromophore in the NIR region is 
hemoglobin. It is important to realize that light absorption in the optical window is 
relatively weak compared to shorter wavelengths, due to the much greater absorption of 
hemoglobin, and longer wavelengths due to the increased absorption of water. In 
principle, the concentration of the main chromophores can be determined by applying 
Equation 1.3.2 to measured absorption coefficients obtained at different wavelengths. 
However, the challenge to applying this approach to tissue is the much larger effect of 
light scattering.  
1.3.3 Photon Scattering 
Light scattering may be thought of as a direction-altering event experienced by photons. 
Mie theory models scattering events by assuming that photons interact with particles that 
can be represented as homogeneous spheres with a refractive index different from the 
surrounding medium (Hergert & Wriedt, 2012). The result of the interaction is an elastic 
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scattering event, meaning the kinetic energy of the redirected photon remains the same 
before and after the interaction. 
Photons emitted into a media are directionally oriented, meaning they most likely 
travel in the forward direction following a scattering event since there is a higher 
probability for small-angle scattering events to occur due to the orientation of the 
scattering cross-section. However, forward directionality diminishes with each 
consecutive scattering event because with each interaction the probability of the 
scattering angle becomes more homogeneous. In a highly scattering medium, the photon 
direction quickly becomes isotropic or diffuse (i.e. the direction is random). The average 
distance traveled by a photon before its path becomes random is given by the inverse of 
the reduced scattering coefficient (µ́s): 
μ ≡ 1 − g ∙ μ     (1.3.3) 
where g is the anisotropy factor defined as the average cosine of the scattering angle. It is 
a measure of the directionality of elastic scattering (i.e. scattering efficiency) and varies 
between 0 and 1. 
Tissue is a highly scattering medium due to the many scattering particles (~108), 
such as cell membranes, nuclei and organelles, and changes in refractive indices within a 
small volume (1 mm3). Therefore, the number of photon scattering events greatly 
outnumbers absorption interactions (µ́s >> µa). The main three scattering constituents of a 
NIR photon, listed in order of scattering frequency, are lipoprotein membranes, 
mitochondria, red blood cells (RBCs), and other cellular components (Cope, 1991). 
These tissue scattering particles can be categorized into two types: static and dynamic; 
the difference is the variation in phase of the interacting photon over time. Although 
scattering events occur more often with static tissue constituents, such as lipoprotein 
membranes and mitochondria, the phase change is time invariant, and the major 
contribution to the temporal phase fluctuations of a NIR photon is due to moving RBCs 
(Bonner & Nossal, 1981; Durduran, Choe, Baker, & Yodh, 2010; Ninck, Untenberger, & 
Gisler, 2010). The variation in phase due to motion is an important phenomenon that can 
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be exploited to measure flow using NIR light and is explained in Section 1.5, but first, the 
mathematical description of light propagation in tissue will be outlined. 
1.3.4 Light Propagation in Tissue 
Maxwell’s equations describe the propagation of electromagnetic radiation in media. In 
tissue, as the electromagnetic radiation travels long distances many scattering events 
occur making solutions to Maxwell’s equations intractable. Simplifications and 
assumptions are required to solve light propagation in a highly scattering media. In this 
section, a brief theoretical derivation of photon diffusion in tissue is presented, 
highlighting important relationships. 
1.3.4.1 Radiative Transfer Equation 
Maxwell’s equations can be approximated by describing light propagation as a stream of 
photons. In particular, the complexities of light travel in tissue can be simplified by 
characterizing individual photon pathlengths with radiative transport theory (Ishimaru, 
1989; Profio, 1989). Radiance is defined as the power of light emitted in a direction per 
unit solid angle [W/cm2/sr]. As radiance travels within tissue, the radiative transport 
equation (RTE) mathematically models energy conservation by describing the 
interactions between particles and radiation: 



 Lr, t, Ω + s'	∇	Lr, t, Ω + μ
 + μLr, t, Ω = μ * Lr, t, ΩPΩ, Ω′dΩ′ + Sr, t, Ω/0    (1.3.4) 
where L(r,t,Ω) is the radiance in a medium at position r, traveling in direction Ω, at time 
t. The scattering phase function, P(Ω,Ω՜ ), represents the probability of scattering into a 
direction Ω՜  from direction Ω. The speed of light in the medium is v, the source term is 
S(r,t,Ω), and dΩ՜  is the solid angle around Ω. 
In an infinitesimal volume, Equation 1.3.4 accounts for energy gains due to the 
light source and photon scattering into the volume. Also, Equation 1.3.4 accounts for 
energy losses due to absorption and scattering out of the volume. Although the RTE 
simplifies Maxwell’s equations, it remains complex with no analytical solution. Further 
approximations are required to solve the RTE. 
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1.3.4.2 Diffusion Approximation 
The diffusion approximation (DA) is the most common solution applied to radiative 
transfer theory for light propagation in tissue, which is assumed to be a highly diffusive 
process. Within the DA, a standard method, known as the P1 approximation, expands all 
angular dependent quantities (i.e. radiance, phase function, and light source) in a 
spherical Legendre series truncated at the first moment. To simplify the RTE, the P1 
approximation assumes the following: 
• A highly scattering medium (i.e. µ́s >> µa). 
• The scattering phase function, P(Ω,Ω՜ ), is isotropic. 
• For the normalized phase function, the scattering amplitude depends on the change 
in direction of the photon only. 
• The source-detector separation is much larger than the typical distance traveled by a 
photon before its direction becomes isotropic (i.e. ρ >> µś). 
• Slow temporal variations in photon flux (i.e. changes in photon flux occur quicker 
than a photon traveling in a single transport length). 
• Light is unpolarized. 
Linearly combining the total power of photons incident on a sphere of cross-sectional 
area [W/cm2], the photon fluence rate, Φ(r,t), is given by: 
Φr, t ≡ *Lr, t, ΩdΩ    (1.3.5) 
and the vector sum of the radiance emerging from an infinitesimal volume [W/cm2] 
defined as the photon flux, J(r,t): 
Jr, t ≡ *Ω ∙ Lr, t, ΩdΩ   (1.3.6) 
Derived in detail elsewhere (L. V. Wang & Wu, 2009), the P1 approximation gives 
radiance independent of direction as: 
Lr, t, Ω = /0Φr, t + 3/0 Jr, tΩ    (1.3.7) 
14 
 
Inserting Equation 1.3.5 into the RTE (Equation 1.3.4) and integrating over all solid 
angles, a relationship that is known as the continuity equation for the fluence rate is 
obtained: 



Φr, t + ∇	Jr, t + μ
r, tΦr, t = Sr, t   (1.3.8) 
Fick’s law describes the diffusion of photons in a scattering medium and provides the 
relationship between fluence rate and flux of a photon by:  
Jr, t = − 45,6 ∇	Φr, t    (1.3.9) 
Where the photon diffusion coefficient is defined as: 
Dr, t ≡ 6389:;<     (1.3.10) 
To describe the radiance of the RTE (Equation 1.3.4) by the photon fluence rate alone, 
Fick’s law (Equation 1.3.9) is substituted into Equation 1.3.8 to obtain the photon 
diffusion equation (PDE). 
1.3.4.3 Photon Diffusion Equation 
In a low absorbing, high scattering medium, such as tissue, the photon fluence rate, 
Φ(r,t), can be described by the PDE: 
=Dr, t∇> − ?μ
r, t − @Φr, t = −?Sr, t  (1.3.11) 
In tissue, the path taken by many individual photons that scatter isotropically and travel 
with a constant velocity between scattering events can be characterized by Equation 
1.3.11. 
1.4 Quantitative Near-Infrared Spectroscopy Techniques 
Accurate modeling of photon propagation through tissue has enabled the development of 
various NIRS methods for quantifying physiological parameters, such as blood flow and 
tissue oxygenation, by use of the DA to estimate the absorption and scattering 
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coefficients (Boas & Yodh, 1997; Maret & Wolf, 1987; D. J. Pine, Weitz, Chaikin, & 
Herbolzheimer, 1988; A. Yodh & Chance, 1995). One method of categorizing the 
different NIRS methods is by the type of light source used, which leads to different 
analytical solutions to the PDE. 
1.4.1 Near-Infrared Techniques  
Near-infrared spectroscopy techniques typically couple the output of a light source to an 
optical fiber placed on the surface of a medium in order to deliver photons into the 
medium. A second optical fiber (or fiber bundle) placed on the same medium will collect 
photons that have escaped, either by reflection or transmission. These detected photons 
carry information about the interactions experienced with scattering particles as they 
travel through the medium. For a thick medium, such as the human head, collecting 
transmitted photons is not feasible due to light absorption and, therefore, reflection 
methods are used commonly. Utilizing this general approach, various NIR methods have 
been developed that are described below. 
1.4.1.1 Continuous-Wave NIRS 
Continuous-wave (CW), which is the simplest NIR method, uses a steady-state light 
source. The change in reflected light intensity measured a few centimeters from the 
source can be characterized by a modified Beer-Lambert Law or the steady-state solution 
to the PDE (Delpy et al., 1988; Wray, Cope, Delpy, Wyatt, & Reynolds, 1988). CW light 
sources can be either broadband (i.e. emits over a wide spectral range) or at multiple 
discrete wavelengths using light emitting diodes (LEDs). Although the equipment is 
inexpensive, measuring only light intensity at a few wavelengths does not provide 
sufficient information to separate the effects of absorption and scatter (Siegel, Marota, & 
Boas, 1999). Consequently, most CW NIRS methods are limited to measuring relative 
changes in the concentrations of chromophores. Estimations of the photon path length 
can be derived separately from Monte Carlo simulations or physical models (Delpy et al., 
1988), but quantification typically relies on more complex NIRS approaches to directly 
measure the effects of scattering (Matcher & Cooper, 1994; Matcher, Cope, & Delpy, 
1993; Nicklin, Hassan, Wickramasinghe, & Spencer, 2003).  
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1.4.1.2 Frequency-Domain NIRS 
This technique modulates the source intensity at a known frequency and uses detectors 
capable of detecting the amplitude and phase change of the modulated light (Fantini et 
al., 1995). Since the phase shift is linearly related to the mean photon pathlength 
(Arridge, Cope, & Delpy, 1992; Patterson, Chance, & Wilson, 1989), FD NIRS provides 
a means of quantifying both µa and µ́s. Knowledge of phase enables direct conversion of 
the detected changes in light attenuation into changes in chromophore concentration. The 
optical properties can be determined by applying a solution to PDE to the measured phase 
shift and modulation amplitude in the frequency domain (Delpy et al., 1988; Madsen et 
al., 1994). Although quantitative information is provided by FD NIRS, it is more 
technically complex than CW NIRS, requiring a frequency generator to modulate the 
emission light and a detector that detects both the changes in phase and amplitude of the 
reflected light. 
1.4.1.3 Time-Resolved NIRS 
Similar to FD NIRS, another method capable of determining the tissue optical properties 
is time-resolved (TR) NIRS. With this approach, pulsed light is emitted into a medium 
and the arrival times of photons, which vary depending on their pathlength, are measured 
(Delpy et al., 1988; Montcel, Chabrier, & Poulet, 2005; Patterson et al., 1989). Millions 
of detected photons are binned based on their arrival time to generate a histogram (Figure 
1-4), which is referred to as the temporal point spread function (TPSF). The dispersion of 
the time-of-flight of the detected photons is due to the difference of paths through the 
medium caused by photon scattering; however, some of the broadening of the TPSF is 
also a result of temporal dispersion within the instrumentation. Therefore, deconvolution 
of the measured TPSF and the measured instrument response function (IRF) isolates the 
true distribution of time-of-flights (DTOF) of the photons in the medium alone (Diop & 
St. Lawrence, 2012). The tissue optical properties can be determined using an analytical 
solution to the PDE (Equation 1.3.11) to characterize the DTOF (Patterson et al., 1989). 
Since late arriving photons have the highest probability of traveling deeper into the 
medium, TR NIRS provides improved depth sensitivity (Diop & St. Lawrence, 2013; 
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Kienle, Glanzmann, Wagnières, & Bergh, 1998; Selb, Stott, Franceschini, Sorensen, & 
Boas, 2005). 
 
Figure 1-4: Measured dispersion of photon arrival times due light interrogating the 
optical instrument components and medium (TPSF) 
1.4.2 Measuring Tissue Oxygen Saturation by NIRS 
As discussed above, the optical properties of tissue can be determined by the combination 
of different NIRS methods and the PDE (Delpy & Cope, 1997). Since absorption depends 
on wavelength (Equation 1.3.2), the concentration of deoxy- and oxy- hemoglobin (i.e. 
[Hb] and [HbO2], respectively) can be determined by measuring light absorption at two 
or more wavelengths (Figure 1-3). NIRS provides a means for assessing oxygen 
metabolism, which is the dominant source of tissue energy. The balance between oxygen 
supply and metabolic energy demands is reflected by tissue oxygen saturation (StO2) and 
is related to hemoglobin concentrations by the definition: 
StO> ≡ BCDEFGBCDEFG;BCDG     (1.4.1) 
where StO2 represents the local average blood oxygenation of tissue and is related to the 
tissue constituents of arterial (SaO2) and venous (SvO2) hemoglobin by: 
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StO> = a ∙ SaO> + b ∙ SvO>   (1.4.2) 
where a and b are fractional constants of the arterial and venous saturation in tissue that 
sum to 1 (Watzman et al., 2000). 
Reductions in StO2 have been shown previously in muscle during occlusion of the 
forearm and during muscle contractions (De Blasi, Fantini, Franceschini, Ferrari, & 
Gratton, 1995; Ferrari, Binzoni, & Quaresima, 1997). Also, in the neonatal ICU, expected 
reductions in StO2 during apnoea were detected (Brazy, Lewis, Mitnick, & Jobsis, 1985), 
and asphyxiated newborns that show an increase in cerebral StO2, relative to healthy 
controls, correlate with abnormal outcome (Zaramella et al., 2007). Tissue oxygen 
saturation is an indicator of metabolism in muscle and brain; however, this measurement 
may be confounded by the delivery of oxygen by blood flow (Boas & Franceschini, 
2011). Therefore, oxygen consumption is better assessed by measuring both StO2 and 
blood flow.  
1.4.3 Measuring Tissue Perfusion by Dynamic Contrast-Enhanced 
NIRS 
NIRS can quantify tissue perfusion by utilizing oxy-hemoglobin as an endogenous flow 
tracer (Edwards et al., 1988; Elwell et al., 1994) or with the aid of an exogenous contrast 
agent (Diop et al., 2010; Elliott et al., 2014). The latter provides superior signal-to-noise 
(SNR) since the absorption change related to perfusion is much greater. Perfusion is 
quantified by dynamic contrast-enhanced (DCE) NIRS using a tracer kinetic model to 
relate the concentration of dye in the tissue to the amount being delivered by arterial 
blood (Brown et al., 2002; Elliott, Diop, Tichauer, Lee, & St. Lawrence, 2010; St. 
Lawrence et al., 2013): 
Ct = CBF ∙ * C
t − u ∙ RuP du  (1.4.3) 
where Ct(t) is the dye concentration in tissue as a function of time (t) measured by NIRS, 
and Ca(t) is the arterial blood concentration measured by a dye oximeter (Brown et al., 
2002). R(t) is defined as the impulse residue function and it represents the fraction of 
tracer in the tissue at time t following an idealized bolus injection at t = 0 (i.e. the injected 
19 
 
tracer can be represented by a delta function with unit area). The flow-scaled impulse 
residue function, CBF·R(t), can be extracted by deconvolution, and its initial height 
equals CBF since by definition R(0) ≡ 1. This method can be used to quantify cerebral 
perfusion, but it does not provide a means for monitoring CBF since each measurement 
requires an injection of the contrast agent (Diop et al., 2010). 
1.4.4 Cerebral Metabolic Rate of Oxygen 
The ability of NIRS to quantify both cerebral oxygenation and CBF makes it possible to 
assess the CMRO2 (Elwell et al., 2005), which is considered a better indicator of tissue 
viability than CBF alone (Powers et al., 1985). The CMRO2 is related to CBF by the Fick 
principle (i.e. conservation of mass): 
CMRO> = CBF ∙ BO>G
 − BO>G    (1.4.4) 
where [O2]a and [O2]v are the oxygen concentration in the incoming arteries and outgoing 
veins, respectively. The former can be determined by pulse oximetry while the latter can 
be estimated from StO2 (Section 1.4.2). Quantification of CMRO2 can be obtained by 
combining StO2 with absolute CBF measurements from DCE NIRS (Section 1.4.3) 
(Tichauer, Brown, Hadway, Lee, & St. Lawrence, 2006; Tichauer, Hadway, Lee, & St. 
Lawrence, 2006; Tichauer et al., 2010). However, real-time CMRO2 monitoring requires 
a perfusion technique capable of measuring CBF continuously. 
1.5 Diffuse Correlation Spectroscopy 
The recent emergence of an optical technique, known as DCS, provides a means of 
monitoring CBF that does not require the injection of an exogenous contrast agent (Boas, 
Campbell, & Yodh, 1995; Buckley, Parthasarathy, Grant, Yodh, & Franceschini, 2014). 
DCS is a variation of another technique, known as dynamic light scattering, which was 
developed in the 1960s to analyze speckle intensity fluctuations (Cummins & Swinney, 
1970; Pecora, 1972). The theory was investigated in dilute “single-scattering” 
experiments to characterize the size of particles (Berne & Pecora, 1976; Riva, Ross, & 
Benedek, 1972; Stern, 1975). Shortly after, “single-scattering” experiments evolved into 
“multiple-scattering” experiments in soft condensed matter by diffusing-wave 
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spectroscopy (DWS) (Bonner & Nossal, 1981; D. Pine, Weitz, Chaikin, & 
Herbolzheimer, 1988). Since DCS is an optical technique that uses NIR light, it has the 
same promising principles as NIRS (i.e. safe, non-invasive, fast temporal resolution, 
probes deep tissue, and is portable). However, it also provides the ability to monitor the 
motion of scatterers, which is dominated by the movement of RBCs in tissue. This 
following section provides the theory of DCS to measure blood flow changes. 
1.5.1 Measuring the Intensity Autocorrelation Function 
As described in Section 1.3, NIR photons propagating into tissue encounter many 
scattering interactions, including from dynamic erythrocytes (Figure 1-5A). At the 
location of a detector on the surface of the interrogated medium, the light electric fields 
constructively/destructively interfere to produce a speckle intensity (i.e. bright and dark 
spots). Due to the motion of RBCs, the phase of interacting photons is altered, which in 
turn, modulate the interference at the detector, causing transient intensity fluctuations 
(Figure 1-5B). Faster moving RBCs cause the speckle intensity fluctuations to occur 
more rapidly, inducing earlier decreases in the temporal coherence, which is a measure of 
the degree of phase correlation (Figure 1-5C).  
 
Figure 1-5: Illustration of diffuse correlation spectroscopy; adapted from (Wesley B 
Baker et al., 2014; Zhou, 2007) 
(A) Single photons are emitted into a homogeneous tissue where they propagate and experience multiple 
scattering events predominantly from moving RBCs. The solid and dotted lines represent the pathlengths of 
two photons measured at time t and at a later time delayed by R (i.e. t + R), respectively. (B) At the detection 
site, temporal intensity fluctuations are measured. (C) Normalized intensity autocorrelation function is 
computed by a correlator board; red and blue decay curves represent fast and slow blood flow, respectively. 
To assess tissue perfusion, a normalized intensity autocorrelation function is 
computed from the measured speckle light intensity fluctuations: 
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 g>ρ, τ ≡ 〈V,V,;W〉〈V,〉F            (1.5.1) 
where, τ is the correlation time and <I(ρ,t)> is the light intensity detected at the tissue 
surface at a distance ρ from the source at time t. Equation 1.5.1 is related to the 
normalized electric field autocorrelation function, g1(ρ,τ), by the Siegert relationship 
(Lemieux & Durian, 1999): 
	g>ρ, τ = 1 + β|gρ, τ|>    (1.5.2) 
where β is the coherence factor of the detection system. 
For a high scattering, low-absorbing medium, the electric field autocorrelation 
function, g1(ρ,τ), satisfies the PDE (Section 1.3.4.3) for a continuous light source (Boas et 
al., 1995; Cheung, Culver, Takahashi, Greenberg, & Yodh, 2001): 
gρ, τ = [\,W〈V,W〉	 =
〈],W∙]∗,;W〉
〈|],|F〉	          (1.5.3) 
where the unnormalized electric field autocorrelation function, G1(ρ,τ), can be modeled 
by the correlation diffusion equation (CDE) (Boas et al., 1995; Skipetrov & Maynard, 
1996).  
1.5.2 Correlation Diffusion Equation 
In 1990’s, an equivalency between correlation transport and photon transport was 
introduced, which treats the transport of correlation through turbid medium similar to 
radiative transport theory (Ackerson, Dougherty, Reguigui, & Nobbmann, 1992). The 
difference between radiative and correlation transport is that the former maintains energy 
conservation whereas the latter accumulates correlation decay from each scattering event 
with dynamic particles resulting in a loss of coherence. This difference is described 
theoretically by scattering. Radiative transport assumes energy is conserved as a photon 
scatters in and out of an infinitesimal volume, whereas correlation transport similarly 
describes a transfer of correlation, except that a photon scattering into the infinitesimal 
volume has accumulated a loss of coherence (i.e. correlation decay). By mathematically 
applying this difference between radiative and correlation transport theory to Equation 
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1.3.4, similarly for a high scattering, low-absorbing medium, the PDE (Equation 1.3.11) 
can be modeled by the CDE (Boas et al., 1995; Skipetrov & Maynard, 1996): 
=Dr, t∇> − ?μ
r, t − μ4> τ@Gr, τ = −?Sr, τ         (1.5.4) 
where µD accounts for the loss of correlation due to dynamical processes (i.e. the motion 
of scatterers) and is given by:   
μ4> τ = 3`4 8μ
 + αµ′ k>〈rτ〉<           (1.5.5) 
where, k0 = 2πn/λ is the wavenumber of light (λ is wavelength and n is the refractive 
index), α is the proportion of moving scatters, which is predominantly RBCs in tissue 
(Bonner & Nossal, 1981; Ninck et al., 2010), to all scatterers and is related to the blood 
volume, and <∆r2(τ)> is the mean-square displacement of the moving scatterers during a 
correlation time τ. 
To relate g2(ρ,τ) to blood flow, the CDE is solved by an appropriate analytical 
model that characterizes the motion of RBCs and the interrogated geometry. This can be 
challenging as the motion of RBCs is not well understood and the geometry, such as the 
adult head, can be complex due to tissue heterogeneities. 
In tissue, the loss of coherence is predominately affected by the movement of 
erythrocytes in the microvasculature (Ninck et al., 2010). Originally, a photon is thought 
to have sequentially scattered off of moving RBCs within different vessels due to the 
torturous nature of microvasculature. Therefore, the direction of moving RBCs relative to 
the multiply-scattered photon is assumed to be random (i.e. <∆r2(τ)> = V2τ2, where V is 
the velocity of the moving scatterers). However, autocorrelation functions are best fit by 
assuming the motion of dynamic scatterers as Brownian diffusion (i.e.  <∆r2(τ)> = 6DBτ, 
where DB is the effective diffusion coefficient). The loss of coherence of the photon may 
be best explained by within-vessel scattering due to tissue shearing, tumbling, and rolling 
experienced by an erythrocyte as it moves within a vessel; however, characterizing the 
motion of dynamic scatterers requires further investigation. The Brownian diffusion flow 
model has been successfully applied to a wide range of tissue types to fit for the αDB term  
(Durduran, Choe, et al., 2010), which is commonly refferred to as a blood flow index 
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(BFI) in tissue. Most applications of DCS, such as the head of neonatal infants, assume a 
semi-infinite homogeneous medium, which is acceptable if the thickness of the 
extracerebral layers is relatively thin (Buckley et al., 2014; Durduran & Yodh, 2014).  
1.5.3 Analytical Solution for a Homogeneous Medium 
Currently, the most common analytical solution applied to analyze DCS data assumes 
light propagates in a semi-infinite (i.e. no light transmission) homogeneous medium. The 
solution for G1(ρ,τ) is given by: 
Gρ, τ = 39:/0 bcde
f5\
5\ −
cdef5\
5F g    (1.5.6) 
where, r1 = [ρ2 + z02]½ and r2 = [ρ2 + (z0 + 2zb)2]½. z0 is the effective depth of the source 
and is defined as 1/µ́s, zb is the extrapolated boundary and is defined as                                  
2D(1+Reff)(1-Reff)-1 (Kienle & Glanzmann, 1999). D is the diffusion coefficient (Equation 
1.3.7) and Reff is the effective reflection coefficient given by 0.493 for the refraction 
indices of tissue and air (Haskell et al., 1994). This solution has been verified against 
many flow modalities to demonstrate quantitative flow changes in various tissues 
(Buckley et al., 2014; Mesquita et al., 2011). When applied to adults, cerebral perfusion 
can be underestimated due to partial volume errors from thick extracerebral layers 
(Durduran et al., 2004; Gagnon, Selb, & Boas, 2008).  
A few approaches have emerged to account for tissue heterogeneity in the adult 
head including the application of a correction factor based on partial volume estimates 
(Durduran et al., 2004). Another approach is to weight the fit of the semi-infinite 
homogeneous model towards shorter correlation times since these are most sensitive to 
longer photon pathlengths (i.e. photons that have most likely propagated in deep tissue) 
(Selb et al., 2014). However, these methods only enhance sensitivity to CBF from the 
measured DCS signal and do not completely separate the effects of light propagation in 
the various tissues. 
An analytical solution to the CDE (Equation 1.5.4) that separates flow in multiple 
tissue layers by accounting for extracerebral tissue thickness have been shown to improve 
the sensitivity to CBF (Gagnon, Desjardins, Jehanne-Lacasse, Bherer, & Lesage, 2008), 
and to detect CBF increases in the motor cortex during a functional task (Jun Li et al., 
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2005). To-date, only a few studies have employed a multi-layer model, and there have 
been no validations of this approach (Jaillon, Li, Dietsche, Elbert, & Gisler, 2007; J Li et 
al., 2008; Jun Li et al., 2005). 
1.5.4 DCS Instrumentation 
To measure g2(ρ,τ), some of the main components include: a continuous-wave, long-
coherent (>5 m) light source, a single-mode detection fiber, and a fast counting board and 
fast detection system (i.e. avalanche photodiode capable of detecting single photons on 
the order of µs). Regarding the source, a long coherence length (typically >5 m) is 
required to ensure the light emitted by the source are spatially in-phase for distances 
much greater than typical photon pathlengths through tissue (<1 m; estimated from 
Figure 1-4). Therefore, the decay of correlation is a result from multiple scattering 
interactions with RBCs in tissue and not due to the laser. A single-mode detection fiber 
has a very small core radius (~2 µm) comparable to the wavelength of light, which 
enables selection of a single scattered electric field component (i.e. receiver mode) to 
maximize speckle contrast. However, the small core diameter and low numerical aperture 
limit SNR, making it difficult to acquire DCS data at larger source-detector distances (>3 
cm), which is often used to improve depth sensitivity. Strategic use of a few-mode 
detection fiber can enhance SNR by increasing the photon count rate, but sacrifices 
speckle contrast (Dietsche et al., 2007; Gisler et al., 1995; He, Lin, Shang, Shelton, & Yu, 
2013). 
A fast detection system, such as a single-photon avalanche photodiode (SPAD), 
and a fast counting board are required for high temporal resolution and high SNR. 
Temporal resolution may be traded in to enhance SNR, but this is not ideal for real-time 
monitoring of tissue blood flow. A multi-tau correlator board bins the photons from a 
time range scale of µs to seconds and computes the autocorrelation function. Recent 
innovative techniques that efficiently select only relevant correlation times have shown to 
improve the speed of data acquisition and reduce noise (Baker et al., 2014; D. Wang et 
al., 2016). Ultimately, this may enhance the depth sensitivity of DCS techniques since 
long photon pathlengths are most likely to travel deep in the tissue and are best 
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representative of the autocorrelation function at early correlation times (Selb et al., 2014), 
which are most susceptible to noise. 
1.6 A Review of Current Applications and Limitations of 
DCS 
Over the past 10 years, the applications of DCS have grown rapidly due to its clinical 
promise (i.e. safe, non-invasive, inexpensive, good depth sensitivity, real-time data 
acquisitions, portability) as a bedside monitor of cerebral perfusion. The clinical 
applications have been supplemented by a plethora of validation studies, which have been 
summarized in a number of recent review articles (Buckley et al., 2014; Durduran, Choe, 
et al., 2010; Durduran & Yodh, 2014; Mesquita et al., 2011; Yodh, 2009). 
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Table 1-1: A list of DCS validation studies; modified from (Mesquita et al., 2011) 
Sample Perturbation Comparison Modality R
2
 Slope Reference 
Mouse 
tumour PDT 
Power Doppler 
ultrasound N/A 0.97 (Menon et al., 2003) 
Rat Hypocapnia Laser Doppler 0.94 1.3 (Durduran, 2004) 
Mouse 
tumour PDT 
Doppler 
ultrasound N/A Agreement 
(Yu, Durduran, Zhou, et 
al., 2005) 
Mouse 
tumour Antivascular therapy DCE ultrasound N/A Agreement (Sunar et al., 2007) 
Human calf 
muscle 
Cuff 
inflation/deflation ASL MRI >0.77 1.5-1.7 (Yu et al., 2007) 
Piglet TBI Fluorescent 
microspheres 0.63 0.4 (Zhou et al., 2009) 
Premature 
neonates Absolute baseline TCD 0.91 0.9 
(Buckley, Cook, 
Durduran, & Kim, 2009) 
Premature 
neonates Absolute baseline TCD 0.53 N/A 
(Roche-Labarbe et al., 
2010) 
Term 
neonates Hypercapnia ASL MRI 0.7 0.85 
(Durduran, Zhou, et al., 
2010) 
Mouse Femoral artery 
occlusion Laser Doppler >0.8 0.96-1.07 (Mesquita et al., 2010) 
Rat Hypercapnia ASL MRI ~0.84 0.75 
(Carp, Dai, Boas, 
Franceschini, & Kim, 
2010) 
Adult 
human 
Pressors and 
hyperventilation Xenon CT 0.73 1.1 (Kim et al., 2010) 
Adult 
human Acetazolamide TCD N/A Agreement 
(Zirak, Delgado-Mederos, 
Martí-Fàbregas, & 
Durduran, 2010) 
Piglet Hypo-/hyper-capnia DCE NIRS 0.93 1.05 (Diop, Verdecchia, Lee, & St Lawrence, 2011) 
Children 
(JV) Hypercapnia PC MRI 0.77 0.91 (Buckley et al., 2012) 
Children 
(SVC) Hypercapnia PC MRI 0.59 0.99 (Buckley et al., 2012) 
Neonates 
CHD 
Absolute 
Hypercapnia PC MRI 0.67 0.40 (Jain et al., 2014) 
Neonates 
CHD Hypercapnia PC MRI 0.62 1.01 (Jain et al., 2014) 
Neonates 
PDA 
Indomethacin 
Infusion DCE NIRS 0.68 0.43 
(Diop, Kishimoto, 
Toronov, Lee, & 
Lawrence, 2015) 
A list of the abbreviations in Table 1-1: A list of DCS validation studies; modified from (Mesquita et al., 
2011): Dynamic contrast enhanced (DCE) NIRS; Arterial spin labeling (ASL) MRI; Phase-contrast (PC) MRI; 
Photodynamic therapy (PDT); Transcranial Doppler ultrasound (TCD); Congenital heart defect (CHD); 
Patent ductus arteriosus (PDA); Superior vena cava (SVC); Jugular vein (JV). 
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Overall, the majority of validation studies listed in Table 1-1 have concluded that 
DCS can accurately track relative changes in blood flow in various tissues. Generally, 
DCS is used to measure relative flow since quantification requires accurate estimation of 
the tissue optical properties (Diop et al., 2011; Irwin et al., 2011; Z. Li et al., 2015). 
However, some validation studies (included in Table 1-1) have correlated BFIs measured 
by DCS with perfusion (i.e. transcranial Doppler ultrasound, ASL-MRI, DCE NIRS, and 
phase-contrast MRI) suggesting that the BFIs measured by DCS represent true perfusion, 
despite its diffusion units [cm2/s] (Buckley et al., 2009; Diop et al., 2011; Jain et al., 
2014; Roche-Labarbe et al., 2010; Yu et al., 2007). The conversion of a BFI obtained by 
DCS into perfusion units (mL/100g/min) can be achieved by calibrating DCS from an 
independent perfusion measurement, such as by DCE NIRS (Section 1.4.3) (Diop et al., 
2011; Gurley, Shang, & Yu, 2012; Z. Li et al., 2015). This combination of DCS and TR 
NIRS also provides a means of quantifying CMRO2 by combining StO2 (Section 1.4.2) 
and CBF measurements. 
1.6.1 Applications of DCS in Various Tissue Types 
Tissue hemodynamics are important for providing sufficient oxygen to meet metabolic 
demands. In particular, highly vascularized tissues, such as brain and tumour, are 
attractive applications to monitor changes in blood flow by DCS.  
Monitoring hemodynamics of skeletal muscle is another growing clinical 
application of DCS, particularly for peripheral artery disease. Following calf muscle 
ischemia, which was induced by ligating a femoral artery in mice, reperfusion was 
established by DCS in 90 % of healthy mice (Mesquita et al., 2010). Another study 
acquired optical data in healthy human arm and leg flexor muscles during arterial cuff 
occlusion detecting rapid drops in blood flow, but only gradual decreases of oxygen 
saturation were found (Yu, Durduran, Lech, et al., 2005). Recently, the BFI measured by 
DCS at baseline has been calibrated by a venous-occlusion technique, in which, the 
increase rate of blood volume following the release of an occluding artery is converted to 
perfusion units by assuming an average hemoglobin concentration and accounting for 
hemoglobin molecular weight (Gurley et al., 2012). Later this calibration technique was 
further investigated to confirm the total hemoglabin increase rate due to venous-occlusion 
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agrees well with BFIs measured by DCS (Z. Li et al., 2015). However, exercise protocols 
are susceptible to motion artifacts that can distort the DCS signal. Co-registration 
techniques are required to separate true blood flow response from motion artifacts 
(Gurley et al., 2012; Shang, Symons, Durduran, Yodh, & Yu, 2010). 
In oncology, DCS has been used to characterize tumour hemodynamics with the 
goals of detecting highly vascularized tumours and assessing the efficacy of therapeutic 
treatments in pre-clinical experiments (Becker, Paquette, Keymel, Henderson, & Sunar, 
2010; Sunar et al., 2007; Yu, Durduran, Zhou, et al., 2005) and clinical studies (Choe et 
al., 2014; Durduran et al., 2005; Sunar et al., 2010; Yu et al., 2006). In 2005, Durduran et 
al. observed increased blood flow in patients with breast tumours, likely due to 
angiogenesis (Durduran et al., 2005). Since this original study, cancer applications of 
DCS have extended to monitoring photodynamic therapy (PDT) of prostate cancer and 
basal cell carcinomas (Becker et al., 2010; Yu et al., 2006). In addition, the effects of 
chemotherapy on breast cancer, and head and neck tumours have been investigated 
(Sunar et al., 2010; Zhou et al., 2007). All studies observed significant flow effects early 
(from minutes to the first week) following cancer therapy treatment, highlighting the 
potential of DCS as a tool for monitoring cancer hemodynamic responses; however, all 
studies had relatively small sample sizes (<8). Recently, a moderate-sized clinical study 
(32 patients) measured significantly high flow in malignant breast cancer by a hand-held 
DCS probe (Choe et al., 2014). These studies illustrate the potential for DCS to identify 
malignant cancer and monitor optically accessible tumours in the clinic. 
1.6.2 Applications of DCS in Brain Tissue 
The primary application of DCS has been to monitor CBF. Due to the appeal that signal 
contamination from extracerebral tissue is minimal and photons predominantly 
interrogate cortical tissue, many animal studies have been conducted in rats, mice and 
piglets (Buckley et al., 2014; Durduran & Yodh, 2014). Animal models that mimic 
neurocritical conditions have been used to demonstrate the capability of DCS to track 
real-time flow changes. For example, in the rat brain, relative CBF during cortical 
spreading depression observed an initially strong increase followed by a sustained 
decrease (Zhou et al., 2006). Shang et al. showed that DCS could detect large reductions 
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in CBF (> 75%) during bilateral occlusion of the common carotid arteries in mice, as well 
as reperfusion following unclipping (Shang, Chen, Toborek, & Yu, 2011). A recent study 
using a TBI mouse model demonstrated that baseline CBF could be used as a biomarker 
of cognitive outcome following repetitive concussions (Buckley et al., 2015). DCS has 
also been used to detect the sizable CBF reduction that occurs following acute TBI in a 
nonimpact inertial rotational swine model (Zhou et al., 2009). 
Due to its good temporal resolution (i.e. order of seconds), DCS has been used to 
detect the CBF response to functional activation in humans. The first application was by 
Durduran et al. who measured the CBF increase in the motor cortex during a simple 
finger tapping task (Durduran et al., 2004). This study paved the way for investigations of 
functional monitoring of cerebral hemodynamics by DCS. For example, various oral 
tasks were investigated to better understand speech impediments, such as stuttering 
(Tellis, Mesquita, & Yodh, 2011). While its adaptation to functional activation tasks 
illustrated the versatility of DCS, its greatest promise is as a bedside monitor in the ICU.  
Clinical studies have investigated patient management techniques, such as 
administering medication and head-of-bed (HOB) strategies. First, administrated dose of 
NaHCO3, which is a common medication for acidemia in the ICU, was observed to 
linearly relate to CBF increases (Buckley et al., 2013). Also, HOB strategies were 
investigated in patients with acute ischemic stroke to observe the effects of CBF by 
adjusting the angle of recline of the patient (Durduran et al., 2009; Favilla et al., 2014). 
Typically, stroke patients resulted in significant increases of CBF by HOB techniques; 
however, some patients responded paradoxically, highlighting the importance of 
monitoring neurocritical management techniques to individualize patient care. 
1.6.3 Hybrid Optical Modality to Measure CMRO2 
As mentioned earlier, the combination of DCS and NIRS provides a safe and non-
invasive means to assess CMRO2 at the bedside (Boas & Franceschini, 2011; Buckley et 
al., 2014; Durduran, Choe, et al., 2010; Durduran & Yodh, 2014). The first study to 
combine photon diffusion methods by a hybrid DCS/NIRS technology measured regional 
blood flow, hemoglobin concentration and blood oxygen saturation in rat brain (Cheung 
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et al., 2001). The appeal for an all-optical hybrid system capable of measuring cerebral 
hemodynamics and cerebral oxygen metabolism in tissue has prompted extensive 
research. Next, a hybrid optical system was used to monitor CMRO2 changes during 
focal cerebral ischemia in rats (Culver et al., 2003), which was adapted to the adult brain 
(Durduran et al., 2004). 
Over the last few years, interest in the use of an all-optical hybrid modality has 
expanded towards studies measuring relative changes of cerebral metabolism in healthy 
infants (Buckley et al., 2009; Goff, Buckley, Durduran, Wang, & Licht, 2010; Roche-
Labarbe et al., 2010). The idea to measure cerebral metabolism with NIRS is not novel 
(Franceschini et al., 2007), but computing CMRO2 with the inclusion of DCS reduced 
intersubject variability (Roche-Labarbe et al., 2010). This combination has been used to 
map developmental changes in the early stages of life, in which the measured average 
metabolism increased by 40 % in newborns over their first 6 weeks of life (Roche-
Labarbe et al., 2010). Roche-Labarbe et al. later reported lower CMRO2 values at lower 
gestational ages (Roche-Labarbe et al., 2012). Furthermore, a couple studies observed 
increases in CMRO2 in the injured neonatal brain compared to healthy infants, and 
suggest CMRO2 is a better biomarker of brain injury than StO2 alone (Grant, Roche-
Labarbe, & Surova, 2009; Lin et al., 2013). Aside from monitoring brain development, a 
number of studies investigated effects of therapeutic treatments in sick infants. For 
example, one study found metabolism to be unaltered during hypercapnia in neonates 
with congenital heart disease, despite significant increases in CBF and oxyhemoglobin 
(Durduran, Zhou, et al., 2010). Recently, another study investigated infants with patent 
ductus arteriosus who underwent treatment by indomethacin, a well-known 
vasoconstrictor, and found reductions in CBF and StO2, despite no changes in CMRO2, 
before and after pharmaceutical ingestion (Diop et al., 2015). Monitoring the 
neurovascular coupling of a developing brain by DCS/NIRS provides a means for early 
detection of brain injury and monitoring the efficacy of therapeutic treatment. 
1.6.4 Limitations 
Despite the employment of DCS in a number of applications, both pre-clinical and 
clinical, there remain some limitations that prevent the translation of DCS to the ICU. 
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These include susceptibility to motion, sensitivity to probe pressure, low SNR, separation 
of blood flow in cerebral and extracerebral tissues, and flow quantification. 
Intensity fluctuations measured by DCS are caused primarily by photon 
interactions with dynamic scatterers in the interrogated medium. However, additional 
fluctuations are falsely detected from static scatterers due to the motion of probes, which 
increase the variability of the estimated BFI (Belau et al., 2010). A few possible solutions 
are suggested, including glueing the fibers with collodion (Yücel, Selb, Boas, Cash, & 
Cooper, 2014), time gating with a dynamometer (Shang et al., 2010), and analytical 
approaches that filter artifacts due to motion, similarly to functional NIRS techniques 
(Cooper et al., 2012). The latter idea is perhaps the most feasible but little work has 
focused on reducing errors due to motion. Current data acquisition setups require the 
optical probes to be secured strongly to the interrogated medium in order to limit motion 
artifacts. 
A more prominent source of error than motion is the effects of contact pressure 
between the skin and the DCS probes. Typical pressure (i.e. 20-55 mmHg) required to 
hold the optical probes in place on the surface of tissue have been shown to influence the 
DCS signal in scalp or muscle (Baker et al., 2015; Mesquita et al., 2013). To avoid errors 
caused by pressure variations, non-contact optical probes have been developed (Cheung 
et al., 2001; T. Li et al., 2013; Yu, Durduran, Zhou, et al., 2005). Although this technique 
is an interesting approach, there are limitations, including detection of stray light and loss 
of depth sensitivity. Recent advancements in non-contact probes show comparable 
performance to contact probes, (Han et al., 2015; He et al., 2015), but further 
technological advancements are required before a non-contact probe can be used to assess 
hemodynamics in deep tissue, such as cortical tissue in adults. Furthermore, applying a 
non-contact emission probe to the head would be highly susceptible to local 
inhomogeneities, such as hair, which limit measurements of the prefrontal cortex via the 
forehead. Advantageously, a contact probe provides optimal optical coupling through 
hair, especially by designs of the light collection tip, such as a funnel-shaped tip, which 
displaces hair from the detection field of view (Dietsche et al., 2007). 
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An unavoidable complication of optical methods is the limited depth penetration 
of NIR light in a highly scattering medium, such as tissue. The highly scattering medium 
makes it difficult to achieve excellent SNR at large source-detector distances since less 
light reflected from the medium is detected. A simple solution to improving the SNR is to 
increase the laser emission power, but to avoid excessive heating of the skin, the output 
power of a continuous laser must be below 28.4 mW (Baker, 2015). In addition, less light 
is collected in DCS compared to other NIRS techniques, due to the requirement of single-
mode detection fibers. Dietsche et al. improved SNR by collecting light from multiple 
fibers, but each fiber must be coupled to its own detector, which can become expensive 
(Dietsche et al., 2007).  
Another approach for improving SNR or depth sensitivity is by developing robust 
instrumentation or data analysis techniques. Rather than computing an autocorrelation 
curve at multiple delay times, single correlation times may be used to monitor flow 
changes, and the early correlation times may be utilized for better depth sensitivity 
(Baker et al., 2014). Also, combining DCS analysis with a software correlator, rather than 
the conventional hardware correlator, may provide better fitting results and is less 
expensive (Dong et al., 2012). Recently, a new software correlator that computes the 
autocorrelation function at selected correlation times was shown to provide temporal 
resolutions capable of detecting heart-rate fluctuations in CBF (Wang et al., 2016).  
The innovative DCS technologies that improve SNR provide a means to 
accurately measure flow changes in deep tissue, such as cortical tissue in the adult head. 
Extracerebral tissues are known to contaminate the optical signal, which underestimates 
the BFI measured by DCS (Durduran et al., 2004; Gagnon, Desjardins, et al., 2008). 
Partial volume errors are a complicated problem with NIR techniques due to the poor 
spatial resolution. Originally, a simple approach of applying a correction factor based on 
partial volume estimates was suggested (Durduran et al., 2004), but extracerebral tissue 
thickness differences between subjects vary the sensitivity of brain tissue. Furthermore, 
techniques that adjust the weight of the fit to early correlation times increase the 
sensitivity to deeper tissue (Selb et al., 2014); however, they do not separate light 
propagation in multiple tissue types. 
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 A method to separate flow indices in different tissue layers (scalp, skull, and 
brain) was used to measure functional activation due to finger tapping (Jun Li et al., 
2005), but only a few studies have investigated the feasibility of using layered models to 
improve the accuracy of CBF monitoring (Gagnon, Desjardins, et al., 2008; Jaillon et al., 
2007; Jun Li et al., 2005). The importance of separating scalp and brain is critical since 
flow in the scalp dominates the DCS signal (Mesquita et al., 2013). A recent algorithm 
has been proposed to separate scalp blood flow (SBF) and CBF by modulating the 
pressure between the tissue surface and optical probes (Baker et al., 2015); however, this 
technique relies on a pressure calibration stage that induces a flow change in the scalp 
only. The authors present an intriguing technique that would be strengthened by 
validation with independent flow measures. A model to separate flow estimates in the 
brain and the scalp without requiring calibration would be ideal. 
Another caveat of flow measured by DCS is the inability to assess absolute 
perfusion. Currently, DCS can only measure relative changes in blood flow due to the 
arbitrary units [cm2/s] of a BFI. Diop et al. proposed an all-optical approach to convert 
the DCS flow index into units of absolute perfusion by measuring CBF by DCE NIRS 
(Diop et al., 2011). This technique could also be extended to monitor CMRO2, which is 
one of the motivations of this thesis.  
1.7 Research Objectives 
The goal of this doctoral work was to develop a non-invasive optical imaging system 
capable of monitoring blood flow and oxygenation in the cerebral microvasculature of 
patients at the bedside. Considering the main goal to develop DCS towards the clinic, the 
following objectives were addressed:  
1. Design and construct an optical imaging system capable of measuring flow and 
oxygenation. 
2. Quantify CMRO2 by an all-optical method. 
3. Investigate the best model to characterize moving scatterers in the brain. 
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4. Develop a multi-layered model to improve depth sensitivity. 
5. Validate DCS with computed tomography perfusion (CTP). 
Each chapter in this dissertation represents an advancement in the field with the ultimate 
goal of developing a safe, non-invasive neuromonitoring device for patients in the ICU. 
1.8 Thesis Outline 
The remainder of the thesis is divided into three chapters that outline published studies 
and a final concluding chapter. 
1.8.1 Measurements of Absolute Cerebral Metabolic Rate of 
Oxygen by a Hybrid Optical Modality that Includes Diffuse 
Correlation Spectroscopy (Chapter 2) 
An all-optical imaging technique was employed to measure changes in absolute CMRO2 
in newborn piglets, which were validated against an invasive gold standard method. This 
chapter is based on the paper entitled “Quantifying the cerebral metabolic rate of oxygen 
by combining diffuse correlation spectroscopy and time-resolved near-infrared 
spectroscopy”, published in the Journal of Biomedical Optics in 2013 by Verdecchia K, 
Diop M, Lee T-Y, and St. Lawrence K. 
1.8.2 Measurements of Cerebral Blood Flow in Pigs by Diffuse 
Correlation Spectroscopy on the Exposed Cortex (Chapter 
3) 
Motivation for describing motion of RBCs as Brownian diffusion is not well understood 
but is applied frequently by DCS studies due to its superior fit than other models. This 
chapter investigates the best flow model to characterize blood diffusion in cortical tissue 
by placing the optical probes directly on the exposed brain of adolescent pigs in order to 
remove any confounding effects of extracerebral tissues. Furthermore, the validity of the 
CBF changes measured by DCS was compared to CTP. This chapter is based on the 
paper entitled “Assessment of the best flow model to characterize diffuse correlation 
spectroscopy data acquired directly on the brain”, published in Biomedical Optics 
Express in 2015 by Verdecchia K, Diop M, Morrison LB, Lee T-Y, and St. Lawrence K. 
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1.8.3 Measurements of Cerebral Blood Flow in Adolescent Pigs by 
Diffuse Correlation Spectroscopy (Chapter 4) 
In the adult head, the extracerebral tissues highly dominate an optical signal resulting in 
underestimating CBF changes by DCS. A multi-layered model was implemented in 
adolescent pigs to separate the blood flow in cerebral and extracerebral tissues. 
Furthermore, the validity of the CBF changes measured by a multi-layered DCS 
technique was compared to CTP. This chapter is based on the paper entitled “Assessment 
of a multi-layered diffuse correlation spectroscopy method to monitor cerebral blood 
flow changes in adults”, published in Biomedical Optics Express in 2016 by Verdecchia 
K, Diop M, Lee A, Morrison LB, Lee T-Y, and St. Lawrence K. 
1.8.4 Conclusion and Future Work (Chapter 5) 
In the final chapter, the main results from the thesis are summarized and a discussion is 
provided on their experimental and clinical implications. Based on the findings in this 
thesis, areas of interest for future work are discussed and principle conclusions are 
presented. 
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Chapter 2  
2 Measurements of Absolute Cerebral Metabolic Rate of 
Oxygen by a Hybrid Optical Modality that Includes 
Diffuse Correlation Spectroscopy 
This chapter is adapted from the paper entitled “Quantifying the cerebral metabolic rate 
of oxygen by combining diffuse correlation spectroscopy and time-resolved near-infrared 
spectroscopy” by Verdecchia K, Diop M, Lee T-Y, St. Lawrence K, published in the 
Journal of Biomedical Optics vol. 18(12) pp. 27007 (2013). 
2.1 Introduction 
Improvements in neonatal intensive care have reduced the mortality rate associated with 
preterm birth, but unfortunately these infants remain at a high risk of neurological 
complications, including learning disabilities and cerebral palsy (Behrman, 2006). 
Preterm infants are vulnerable to ischemic and hemorrhagic brain injury in part because 
of an underdeveloped cerebral vasculature, including limited or impaired autoregulation 
(Volpe, 1990). As a result, unstable arterial blood pressure could lead to dangerous 
fluctuations in cerebral blood flow (CBF). Recent studies using near-infrared 
spectroscopy (NIRS) to monitor cerebral blood oxygenation have reported that periods of 
impaired autoregulation are not uncommon in preterm infants; however, a correlation 
between the occurrence of impaired autoregulations and brain lesions was not observed 
(O’Leary et al., 2009; Soul et al., 2007; Wong et al., 2008). 
Using cerebral blood oxygenation to identify critical CBF thresholds is potentially 
confounded by the indirect relationship between cerebral blood oxygenation and CBF, as 
the former also depends on the cerebral metabolic rate of oxygen (CMRO2), the cerebral 
blood volume (CBV) and arterial oxygen saturation (J. Cooper et al., 2011). An 
alternative approach would be to combine NIRS with diffuse correlation spectroscopy 
(DCS), an emerging optical method sensitive to CBF (Boas & Yodh, 1997; Cheung, 
Culver, Takahashi, Greenberg, & Yodh, 2001; Durduran et al., 2010). This combination 
has the advantage of providing a means of monitoring both CBF and CMRO2 (Durduran 
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et al., 2004; Roche-Labarbe et al., 2010, 2012). The latter can be determined from blood 
oxygenation and flow measurements and is considered a more sensitive indicator of 
tissue viability (Boas & Franceschini, 2011; Powers, Grubb, Darriet, & Raichle, 1985). 
For example, CMRO2 has been shown to be more sensitive to the severity of cerebral 
hypoxia-ischemia than NIRS oxygenation measurements alone (Tichauer, Brown, 
Hadway, Lee, & St. Lawrence, 2006; Tichauer, Elliott, Hadway, Lee, & St. Lawrence, 
2009). The combination of NIRS and DCS could therefore help identify clinically 
significant passive-pressure CBF by detecting flow fluctuations large enough to affect 
cerebral energy metabolism. 
The purpose of this study was to demonstrate that changes in absolute CMRO2 
could be measured by combining NIRS and DCS. In order to quantify CMRO2, 
techniques for measuring absolute CBF and cerebral blood oxygenation are required. In 
this study, relative blood flow changes measured by DCS were converted into units of 
CBF using a bolus-tracking time-resolved (TR) NIRS technique to measure baseline CBF 
(Diop, Verdecchia, Lee, & St. Lawrence, 2011). Cerebral blood oxygenation was 
determined from multi-wavelength TR NIRS measurements. The accuracy of the 
oxygenation measurements was assessed by directly measuring blood oxygenation in the 
sagittal sinus. The sensitivity of the hybrid approach to changes in CMRO2 was 
investigated by manipulating cerebral metabolism in newborn piglets by altering the 
anesthetics and by injecting sodium cyanide, a mitochondrial inhibitor (C. Cooper et al., 
1999; Tichauer, Hadway, Lee, & St. Lawrence, 2006). 
2.2 Methods 
2.2.1 Animal Model 
This study was approved by the Animal Use Subcommittee at Western University. 
Experiments were carried out on newborn Duroc pigs (<3 days old). All surgical 
procedures were performed while piglets inhaled 3-4% isoflurane. Piglets were 
tracheotimized and mechanically ventilated on an oxygen/medical air mixture. Catheters 
were inserted into an ear vein, the left femoral artery, and superior sagittal sinus through 
a burr hole drilled into the skull. The ear catheter was used to inject the light absorbing 
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dye, indocyanine green (ICG) (Sigma-Aldrich, Missouri, US), and the different drugs 
used in the experiment. The femoral and sagittal sinus catheters were used to acquire 
blood samples in order to determine the oxygen saturation of arterial blood (SaO2) and 
cerebral venous blood (SvO2), respectively. The superior sagittal sinus primarily drains 
the cerebral cortex, which is the brain region interrogated by the optical probes (Scremin, 
Sonnenschein, & Rubinstein, 1982). The femoral line was also used to monitor heart rate 
(HR), blood pressure, blood gases (paCO2 and paO2), and blood glucose (BG). A 1-2 ml 
infusion of a 25% glucose solution was administered intravenously if glucose levels fell 
below 4.5 mmol/L. A heated water mattress was used to maintain rectal temperature 
between 37.5 and 38.5°C throughout the experiment. After surgery, the optical probes 
were positioned on the scalp using a custom-made probe holder with a source-detector 
separation of 20 mm. A separation of 10 mm between the probes from the two optical 
systems ensured that they interrogated roughly the same brain region. No data were 
acquired for at least 30 minutes following surgery to ensure the piglet was 
physiologically stabile. Baseline conditions were identified by blood samples revealing 
normal paCO2 and paO2: 38-42 mmHg and 100-170 mmHg, respectively (Reivich, 1964). 
2.2.2 Experimental Procedure 
Five different cerebral metabolic states were induced by manipulating the anesthetics and 
by injecting sodium cyanide. Following a change of condition, data acquisition was 
delayed by approximately 5 min to allow time for cerebral metabolism to stabilize. Under 
each condition, DCS was used to measure the blood flow index (BFI) and multi-
wavelength TR NIRS was used to measure the oxygen saturation of cerebral tissue 
(ScO2) (see instrumentation section). Blood samples (0.3-0.5 ml) were drawn from the 
femoral artery and the sagittal sinus to determine SaO2 and SvO2, by hemoximetry 
(ABL80 Flex Co-ox, Radiometer, Copenhagen, DK). The DCS and TR NIRS data were 
acquired in three blocks during each condition (Figure 2-1). In each block, 96 TR NIRS 
measurements were acquired with an integration time of 1 s and 20 DCS measurements 
were acquired with an integration time of 30 s. All data sets for each condition were 
acquired within approximately 45 minutes. 
56 
 
 
Figure 2-1: Diagram of the experimental protocol 
An experimental protocol diagram showing the induced metabolic conditions in chronological order with the 
sequence of measurements acquired at each condition. The solid boxes are distinctive steps, whereas the 
dotted box is recurring for each induced condition numbered I-V. 
Initial baseline measurements were acquired under 1.75-2% isoflurane mixed with 
a combination of medical air and oxygen to maintain normal paO2. In addition to the 
standard data acquisition protocol, CBF was measured by a dynamic contrast-enhanced 
TR NIR method using ICG as an intravascular contrast agent (Brown et al., 2002). This 
method requires injecting an intravenous bolus of ICG (0.01 mg/kg), followed by 
measuring the time-varying concentration of ICG in arterial blood and the brain. The 
brain ICG concentration curve was determined by acquiring a series of TR NIR 
measurements at a sampling rate of 400 ms. The arterial concentration curve was 
measured using a pulse dye densitometer (DDG 2001, Nihon Kohden, Tokyo, JP) 
attached to a foot. Three successive sets of ICG data were acquired to improve the 
precision of the baseline CBF measurement. Successive ICG injections were separated by 
10 min to allow time for ICG clearance from the previous injection. The average value of 
CBF was used to convert subsequent DCS BFI measurements into units of CBF (Diop et 
al., 2011). 
Following the baseline measurements, TR NIRS and DCS were used to measure 
ScO2 and the BFI, respectively, under four conditions. First, CMRO2 was increased by 
discontinuing isoflurane and starting an intravenous infusion of fentanyl (0.02 mg/kg/h) 
combined with inhalation of 70% nitrous oxide (N2O). Second, the barbiturate 
pentobarbital (5 mg/kg) was injected intravenously to decrease CMRO2. Cerebral energy 
metabolism was further reduced by switching off the fentanyl/N2O mixture, returning the 
piglet to isoflurane (1.75-2%), and administering another 5 mg/kg of pentobarbital. For 
the final condition, sodium cyanide was injected intravenously at a dose of 5 mg/kg. This 
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non-lethal dosage of cyanide is insufficient to completely inhibit mitochondrial function 
(Sakamoto et al., 2001); however, it is sufficient to reduce mitochondrial respiration (C. 
Cooper et al., 1999). 
2.2.3 Instrumentation 
2.2.3.1 Time-Resolved NIRS System 
The TR instrument for the ScO2 measurements consisted of three picosecond diode lasers 
emitting at 760, 802 and 830 nm (LDH-P-C-810, PicoQuant, Berlin, DE). The output and 
pulse repetition rate of each laser were set to 1.4 mW and 29.3 MHz, respectively. A 
variable neutral density filter (NDC-50-4M, Thorlabs, Newton, New Jersey, US) was 
placed in front of each laser to adjust the intensity of the beam before the light was 
coupled into a multimode fiber (emission probe: N.A. = 0.22, core = 400 µm, 4.7 mm 
outer diameter; Fiberoptics Technology, Pomfret, Connecticut, US). Fibers of different 
lengths, forming a bundle, were used to provide time multiplexing (Contini et al., 2006). 
For the ICG bolus-tracking measurements, only the 802 nm laser was used at a repetition 
rate of 80 MHz to optimize the signal-to-noise ratio (SNR) (Diop, Tichauer, Elliott, 
Migueis, & Lee, 2010). 
Reflected light from the head was collected with a 1.5 m long multimode fiber 
placed 20 mm from the emission fiber bundle on the piglet’s intact head. The collected 
photons were then sent to a Peltier-cooled photomultiplier tube (PMT) (PMC-100, 
Becker & Hickl, Berlin, DE), coupled to a time-correlated single photon counting module 
(SPC-134, Becker & Hickl, Berlin, DE). Temporal point spread functions (TPSFs) were 
computed by synchronizing the photon detection with the laser pulse trigger provided by 
the driver (PDL 828, PicoQuant, Berlin, DE). Each TPSF was acquired for one second 
for the oxygenation measurements and 400 ms for the ICG bolus-tracking method. 
Temporal dispersion caused by the system was corrected for by measuring the instrument 
response function (IRF) (Diop, Tichauer, Elliott, Migueis, Lee, et al., 2010). To avoid 
artifacts such as instrument temporal drift, the TR NIRS system was allowed a 1.5 h 
warm up delay period prior to the experiment (Diop, Tichauer, Elliott, Migueis, & Lee, 
2010; Ntziachristos & Chance, 2001). 
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2.2.3.2 Diffuse Correlation Spectroscopy 
The DCS light source was a continuous-wave laser emitting at 785 nm (DL785-100-S, 
CrystalLaser, Nevada, US) with a maximum output power of 100 mW and a coherence 
length greater than 5 m. Similar to the time-resolved setup, the laser beam was first 
attenuated by a variable neutral density filter (NDC-50-4M, Thorlabs, New Jersey, US) 
and then coupled into an emission fiber (emission probe: N.A. = 0.22, core = 400 µm, 4.7 
mm outer diameter; Fiberoptics Technology, Connecticut, US). Photons scattered from 
tissue were detected at a distance of 20 mm away from the emission probe using a 4-m 
single-mode fiber (SMF-28e+, N.A. = 0.14, core = 125 µm, single-mode cutoff 
wavelength at 1260 nm). Since the detection fiber is a few-mode fiber at the laser 
emission wavelength, the fiber was wrapped into a 15 cm coil to attenuate the higher-
order modes by converting them into non-propagating modes (Dietsche et al., 2007; Diop 
et al., 2011; Gisler et al., 1995). Photons were detected by a single photon counting 
module (SPCM-AQR-15-FC, PerkinElmer Canada Inc, Quebec, CA). The output from 
the detector was sent to a correlator board (DPC-230, Becker & Hickl, Berlin, DE) to 
compute the normalized intensity autocorrelation function. 
2.2.4 Data Analysis 
2.2.4.1 Measuring Cerebral Oxygen Saturation by TR NIRS 
Brain tissue optical properties (i.e. the absorption and reduced scattering coefficients, µa 
and µ́s, respectively) were quantified using the solution to the diffusion approximation for 
a semi-infinite turbid medium with extended boundary conditions (Kienle & Patterson, 
1997). The three sets of TPSFs collected at each condition were averaged together and 
were fit by the theoretical model convolved with the measured IRF (Ntziachristos & 
Chance, 2001). Initial values for µa, µś, and an amplitude scaling factor were obtained by 
analyzing the baseline data with a three-parameter non-linear fitting routine (Diop, 
Tichauer, Elliott, Migueis, Lee, et al., 2010). The amplitude term was included in the 
fitting to take into account variations in laser power, detection gain and coupling 
efficiency (Diop, Tichauer, Elliott, Migueis, Lee, et al., 2010; Ntziachristos & Chance, 
2001). To improve the stability of the fitting algorithm, the TPSFs were analyzed for each 
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metabolic condition using only µa as a fitting parameter; µś and the amplitude scaling 
factor were fixed to the values retrieved from the three-parameter fit at baseline. This 
approach was reasonable since the metabolic changes only affect blood oxygenation and 
not tissue scattering properties. However, in more extreme conditions that could also alter 
light scattering, such as large changes in the total hemoglobin concentration (Paunescu et 
al., 2001), µś could be included as a fitting parameter. The concentrations of oxy- and 
deoxy-hemoglobin ([HbO2] and [Hb], respectively) were derived from the measured µa 
values using the known wavelength-dependent extinction coefficients and assuming a 
cerebral water content of 85% for neonatal pig (Holland, Haas, Norman, Brant-Zawadzki, 
& Newton, 1986). Cerebral oxygen saturation, ScO2, was defined as: 
ScO> = BCDEFGBCDEFG;BCDG      (2.1) 
2.2.4.2 Measuring Absolute CBF by TR NIRS 
The methodology underlying the TR NIRS bolus-tracking technique for quantifying 
CBF, which is used extensively with imaging modalities such as magnetic resonance 
imaging and computed tomography (Wintermark et al., 2005), assumes that the 
microvasculature can be modeled as a linear time-invariant system. For this application, 
linearity means that the contrast agent concentration in brain tissue is linearly 
proportional to the concentration in arterial blood, and time-invariance implies that the 
hemodynamic properties must remain constant during the acquisition period. Under these 
assumptions, the time-varying concentration of ICG in tissue, Ct(t), is related to the 
arterial blood ICG concentration curve, Ca(t), by the convolution operator: 
Ct = CBFhi * C
t − uRuP du    (2.2) 
where CBFTR denotes the CBF measurement obtained by the TR NIRS method and R(t) 
is the impulse residue function, which represents the fraction of ICG in the tissue at time t 
following an idealized unit impulse injection at t = 0 (Zierler, 1965). Ct(t) is determined 
from change in µa due to the passage of ICG through the cerebral microvasculature and 
Ca(t) was measured by the DDG as outlined in Section 2.2 (Diop, Tichauer, Elliott, 
Migueis, Lee, et al., 2010). The flow-scaled impulse residue function, CBFTR R(t), was •
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extracted from Ca(t) and Ct(t) by performing a deconvolution and its initial height equals 
CBFTR, since by definition R(0) = 1 (Brown et al., 2002). 
2.2.4.3 Measuring Changes in CBF and CMRO2 by TR NIRS 
The DCS data from each cerebral metabolic condition were analyzed by the solution to 
the correlation diffusion equation for a semi-infinite homogeneous medium assuming 
Brownian motion of scatterers (Boas, Campbell, & Yodh, 1995; Boas & Yodh, 1997; 
Cheung et al., 2001). The model was fit to the normalized intensity autocorrelation 
function (g2) using the µa and µś values obtained by TR NIRS. The fitting parameters 
were a scaled diffusion coefficient, which is referred to as the BFI, and a coherence factor 
(β) (Diop et al., 2011). The change in the BFI at a given condition relative to baseline, 
denoted rCBF, is given by: 
rCBF = jkVlmnopqpmnjkVr9stpnsjkVr9stpns     (3.3) 
The BFI can be converted into units of CBF (ml/100g/min) using the baseline CBF 
measurement determined by the TR NIRS bolus-tracking method: 
CBF = CBFhi · 1 + rCBF     (3.4) 
The CMRO2 (ml O2/100g/min) for each metabolic state was determined by conservation 
of mass (i.e. the Fick principle), which assumes that the amount of oxygen consumed in 
the tissue is equal to the arteriovenous oxygen difference (Siesjo, 1978): 
CMRO> = CBF ∙ K ∙ BtHbG ∙ SaO> − SvO>    (3.5)  
where, SaO2 and SvO2 are the arterial and venous oxygen saturations, respectively, K is 
the oxygen carrying capacity of hemoglobin (1.39 ml of O2 per g of Hb) (Dominguez de 
Villota, Ruiz Carmona, Rubio, & de Andrés, 1981), and [tHb] is the total hemoglobin 
concentration. In these experiments, SaO2 was measured by pulse oximetry, [tHb] was 
determined from the average of two baseline arterial blood samples and CBF was 
determined from the calibrated DCS blood flow measurements. The remaining parameter 
SvO2 was determined directly from the sagittal-sinus blood samples and also from the TR 
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NIRS ScO2 measurements. Equation 3.5 neglects the contribution of dissolved oxygen in 
plasma, which is reasonable at normal paO2 values (Brown, Hadway, & Lee, 2003; 
Elwell et al., 2005). For TR NIRS, SvO2 was determined from ScO2 by assuming the 
cerebral blood volume is comprised of a known venous volume fraction (fv) since ScO2 
represents the average cerebral blood oxygenation: 
SvO> = xyEFz{x
EFz{     (3.6)  
For this study fv was set to 0.75 (Brun, Moen, & Borch, 1997; Ijichi et al., 2005; 
Mchedlishvili, 1986; Watzman et al., 2000) and using Equation 3.6, the Fick principle for 
the optical measurements is given by: 
CMRO> = |jk∙}∙BCDGz{ ∙ SaO> − ScO>    (3.7) 
2.2.5 Statistical Analysis 
Statistical analyses were conducted using SPSS 20.0 (SPSS, Chicago, IL). A repeated 
measures analysis of variance (ANOVA) was used to identify significant differences in 
SvO2 and CMRO2 between metabolic conditions and between the NIRS and blood-
sampling methods. Bland-Altman analysis was used to compare corresponding CMRO2 
measurements from the two methods (Altman & Bland, 1983). Post-hoc analyses were 
conducted to identify significant differences at each condition, with respect to baseline 
values, for all measured parameters. Statistical significance was defined as p < 0.05 and 
all data are presented as mean ± standard error of the mean (SEM) unless otherwise 
noted. In one animal, measurements were not acquired during the fentanyl/N2O-
pentobarbital condition, which was corrected for by using the Missing Value Analysis 
(MVA) regression algorithm (Graham, 2009). 
2.2.6 Error Analysis 
A Monte Carlo type approach was conducted to investigate how errors in the baseline 
parameters would affect subsequent µa measurements from the one-parameter fitting 
routine. First, a theoretical TPSF was generated using the solution to the diffusion 
approximation for a semi-infinite homogeneous medium and a set of typical experimental 
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values of the scaling amplitude, µa and µś (8000, 0.255 cm-1 and 8.62 cm-1, respectively) 
(Kienle & Patterson, 1997). The simulated TPSF was convolved with an experimental 
IRF and Poisson noise added to reflect typical experimental data. The noisy TPSF was 
analyzed by the same non-linear fitting routine used with the experimental data to 
generate best-fit estimates of the baseline parameters. Next, another noisy TPSF was 
generated using the initial input values, and a one-parameter fit performed to extract an 
estimate µa. In this step the values of the amplitude factor and µś were set to the estimates 
from three-parameter fit. The entire procedure was repeated 5000 times to generate a 
distribution of best-fit values for each fitting parameter. 
To determine the error in CMRO2 due to uncertainties in the two parameters 
measured under each condition (i.e. BFI and ScO2), the SEM of each parameter was 
determined from the series of measurements acquired at baseline (i.e. 60 and 288 
measurements for BFI and ScO2, respectively). A repeated measures ANOVA was used 
to determine the precision of the baseline CBF values measured by the TR NIRS bolus-
tracking method. 
2.3 Results 
A total of 12 piglets were studied; however, 3 were excluded because the sagittal sinus 
was inadvertently punctured during the insertion of the catheter. A puncture caused blood 
to leak into the cerebral spinal fluid, resulting in erroneous NIRS measurements of 
[HbO2] and [Hb] (Tichauer, Hadway, et al., 2006). One additional experiment was 
excluded due to technical errors with the TR NIRS system, which results in incomplete 
TPSFs. The average physiological parameters at each metabolic condition from the 8 
successful experiments (3 male, 5 female, mean weight = 1.62 ± 0.09 kg, mean age = 
1.88 ± 0.35 days) are given in Table 2-1. 
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Table 2-1: Physiological parameters during different cerebral metabolic levels 
Physiological 
 Parameter 
Baseline Fentanyl/N2O 
Fentanyl/N2O 
+ Pentobarbital 
Pentobarbital Cyanide 
Temperature (°C) 37.8 ± 0.2 37.9 ± 0.1 37.9 ± 0.2 37.4 ± 0.2 37 ± 0.2* 
pH 7.47 ± 0.02 7.46 ± 0.02 7.46 ± 0.01 7.46 ± 0.01 7.35 ± 0.02* 
paCO2 (mm Hg) 40.1 ± 0.4 39.6 ± 0.8 38.7 ± 0.7 39.8 ± 0.6 43.3 ± 2.1 
paO2 (mm Hg) 124 ± 8 72 ± 5* 76 ± 5* 97 ± 8 135 ± 22 
MAP (mm Hg) 42 ± 2 69 ± 2* 82 ± 4* 35 ± 3 27 ± 2* 
HR (min-1) 157 ± 9 241 ± 12* 250 ± 14* 165 ± 11 176 ± 7 
pH = arterial pH; paCO2 = partial pressure of carbon dioxide in the blood; paO2 = partial pressure of oxygen 
in the blood; MAP = mean arterial blood pressure; HR = heart rate 
* p<0.05 compared to parameter value under baseline conditions. 
Average ± SEM 
Of all the measured parameters, only paCO2 showed no significant differences 
between conditions. Blood pH and rectal temperature were significantly different after 
injecting sodium cyanide due to the systemic effect of the drug on metabolism. 
Significant differences in paO2 were found under the two conditions involving 
fentanyl/N2O, which can be explained by a reduction in the inhaled oxygen fraction 
during 70% N2O inhalation. Both HR and MAP showed general changes with the 
different anesthetics as expected (Siesjo, 1978). The average [tHb] measured under 
baseline conditions from the hemoximeter was 8.6 ± 0.8 g/dl. The tissue optical 
properties measured under baseline conditions at 760, 802 and 830 nm, were 7.99 ± 0.47, 
8.63 ± 0.59, and 8.55 ± 0.86 cm-1 for µ s' and 0.251 ± 0.016, 0.240 ± 0.012, and 0.248 ± 
0.009 cm-1 for µa, respectively. 
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Figure 2-2: Measured DCS decay curves during various levels of cerebral 
metabolism 
A sample of DCS decay curves taken from an experiment collected with a sampling time of 30 seconds and 
average count rate of 441 ± 17 kHz. Each curve shown was obtained from the same piglet at a different 
induced metabolic condition. The steeper the decay curve the larger the BFI retrieved and ultimately the 
faster CBF. 
Figure 2-2 shows a sample of DCS intensity autocorrelation curves collected from 
each induced metabolic condition during a single experiment. A steeper DCS decay curve 
is represented by a larger BFI value, indicating faster blood flow. Typical arterial and 
brain ICG concentration curves obtained with the DDG and TR NIRS, respectively, are 
shown in Figure 2-3. The derived baseline CBF value obtained from the ICG data sets 
were used to calibrate all subsequent BFI values obtained by DCS. The measured CBF 
values obtained from the dynamic contrast-enhanced technique ranged from 19 to 50 
ml/100g/min with an average of 32 +/- 4 ml/100g/min. 
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Figure 2-3: Dynamic contrast-enhanced arterial/tissue time-course curves of ICG 
A sample of raw data showing a tissue and an arterial curve measured during the ICG bolus tracking 
experiment. The black curve represents the tissue curve measured with the TR NIRS technique whereas the 
red curve is the arterial curve obtained from the DDG. 
Significant differences were observed in all the BFI values listed in Table 2-2 
compared to baseline, except when pentobarbital was injected while under fentanyl/N2O 
anesthesia. No statistical significant differences were observed between conditions for the 
retrieved baseline β value of 0.157 ± 0.001 which was also in agreement with the 
measured value obtained by Diop et al. (Diop et al., 2011). No significant differences 
were observed in SaO2 at any of the conditions. A repeated measures ANOVA showed a 
significant overall effect by condition for SvO2 [F3,36 = 8.596, Power > 0.99, p<0.01], but 
there was no significant effect by technique [F1,14 = 0.007, p>0.9]. Similarly, there was a 
significant effect by condition for CMRO2 [F3,36 = 59.707, Power > 0.99, p<0.01], but no 
significant effect by technique [F1,14 = 0.014, p>0.9]. These results indicate that the 
various conditions altered cerebral energy metabolism, but there were no significant 
differences in the SvO2 and CMRO2 measurements between the sagittal sinus blood 
measurements and the DCS/NIRS method. 
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Table 2-2: NIRS and blood sample measurements 
Parameter Baseline Fentanyl/N2O 
Fentanyl/N2O 
+ Pentobarbital 
Pentobarbital Cyanide 
BFI (cm2/s) x 109 61 ± 6 92 ± 10* 62 ± 6 30 ± 5* 28 ± 4* 
SaO2 (%) 99.9 ± 0.1 98.8 ± 0.7 98.7 ± 0.7 99.7 ± 0.6 95.8 ± 2.3 
ScO2 (%) 69 ± 2 65 ± 3 61 ± 2 57 ± 3* 59 ± 4 
SvO2 – Blood (%) 62 ± 5 55 ± 5 41 ± 5** 42 ± 6** 46 ± 8** 
SvO2 – NIRS (%) 58 ± 3 54 ± 4 48 ± 3** 42 ± 4** 46 ± 5** 
CMRO2 – Blood 
(ml O2/100g/min) 
1.31 ± 0.21 2.25 ± 0.25** 2.01 ± 0.22 0.99 ± 0.18 0.76 ± 0.15** 
CMRO2 – NIRS 
(ml O2/100g/min) 
1.45 ± 0.18 2.41 ± 0.32** 1.81 ± 0.21 0.99 ± 0.17 0.80 ± 0.15** 
BFI = blood flow index; SaO2 = saturated arterial oxygen; ScO2 = saturated cerebral oxygen; SvO2 = 
saturated venous oxygen; NIRS = near-infrared spectroscopy; CMRO2 = cerebral metabolic rate of oxygen 
* p<0.05 compared to parameter value under baseline conditions. 
** p<0.05 compared to parameter value under baseline conditions for both techniques combined. 
Average ± SEM 
 
Figure 2-4: Mean values of SvO2 and CMRO2 after intake of various 
anesthetics/drugs 
Average SvO2 and CMRO2 values at each induced condition comparing both techniques. The darker grey 
bars represent the NIRS technique, the lighter grey bars represent the blood oxygen sample method, and 
the error bars are standard error of the mean. Here * indicates p<0.05 compared to the parameter value 
under baseline conditions for both techniques combined. 
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Figure 2-4 illustrates the average SvO2 and CMRO2 measurements obtained from 
the blood sample and DCS/TR-NIRS techniques under the different conditions. 
Measurements were obtained over a range from 25 to 70 % for SvO2 and from 0.3 to 4 ml 
O2/100g/min for CMRO2. A Bland-Altman plot of the difference between individual 
CMRO2 measurements from the two techniques is shown in Figure 2-5. The mean 
difference was 0.027 ml O2/100g/min with limits of agreement (i.e. 95% boundaries) of 
0.861 and -0.807 ml O2/100g/min. 
 
Figure 2-5: Bland-Altman analysis of CMRO2 
A Bland-Altman plot demonstrating the difference between NIRS and blood oxygen sample CMRO2 
measurements plotted against the average. Each colour represents a different piglet. The dotted line 
represents the average difference between the two techniques; 0.027 ml O2/100g/min. The solid lines are 
the bias lines which represent the region boundaries for which 95% of the differences lie within; 0.027 ± 
0.834 ml O2/100g/min. 
Figure 2-6 shows the predicted relationship between errors in the baseline optical 
properties to the errors in the amplitude factor as determined from the Monte Carlo 
simulations. The figure demonstrates that at typical experimental noise levels, µś and µa 
were relatively insensitive to errors in the amplitude factor. For example, the error in 
either µ́s or µa was only 6% in the extreme case of a 30% error in the amplitude factor. 
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From the Monte Carlo simulations, the coefficient of variation of µa for the one-
parameter fitting routine was 1.7%. The small magnitude of this error was also reflected 
in the SEM of ScO2 (0.1%) determined from the series of baseline measurements. 
Similarly, the SEM of the baseline BFI was 2%. The repeat measurements of absolute 
CBF from the bolus tracking method indicated that this was the greatest source of error 
with an estimated precision of 11.7%. 
 
Figure 2-6: An error analysis of a three-parameter fit (µa, µ́s, and amplitude factor) 
of the diffusion approximation to TR NIRS data 
An error analysis comparing the effects of noisy experimental data on a three parameter fit (µa, µ́s, and 
amplitude factor) from the diffusion approximation. Black represents µa and red represents µs', while each 
data point represents the error in optical properties corresponding to the error in the amplitude factor from 
the three parameter fit. The generated noise for 5000 simulated TPSFs had an average variance of 16.41 ± 
0.05. 
2.4 Discussion 
The main finding of this study was that changes in absolute CMRO2 could be measured 
by combining two near-infrared techniques: DCS and TR NIRS. This was accomplished 
by combining quantitative CBF and SvO2 measurements obtained by a previously 
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validated DCS/TR-NIRS approach and multi-wavelength TR NIRS, respectively. The 
accuracy of the SvO2 measurements was verified by comparison to direct measurements 
of cerebral blood oxygenation obtained from sagittal sinus blood samples. CBF, SvO2 
and CMRO2 were measured over a metabolic range from approximately 0.3 to 4 ml 
O2/100g/min with no evidence of any level-dependent bias in either the SvO2 or CMRO2 
measurements (Figure 2-4 and Figure 2-5). DCS and NIRS have been combined 
previously to measure relative changes in CMRO2 (Durduran et al., 2004, 2010; Roche-
Labarbe et al., 2010, 2012; Zirak, Delgado-Mederos, Martí-Fàbregas, & Durduran, 
2010); however, this is the first study to use this combination to quantify CMRO2. The 
success of this combined optical approach ultimately depends on the accuracy of the 
underlying CBF and ScO2 measurements. A number of studies have demonstrated the 
ability of DCS to track relative CBF (Buckley, Cook, Durduran, & Kim, 2009; Carp, Dai, 
Boas, Franceschini, & Kim, 2010; Diop et al., 2011; Kim et al., 2010; Zhou et al., 2009). 
In particular, Zhou et al., reported a strong correlation between changes in CBF measured 
by DCS compared to those measured by fluorescent microspheres in newborn piglets 
(Zhou et al., 2009). Similarly, we previously reported a strong correlation between CBF 
measurements obtained by the bolus-tracking TR NIRS technique and the BFI 
determined from DCS (R2 = 0.93) (Diop et al., 2011). 
In our previous study, a single pulsed laser was used to measure the absorption 
changes caused by the flow of ICG through brain tissue (Brown et al., 2002). 
Determining [HbO2] and [Hb], and thereby ScO2, requires measuring the tissue optical 
properties at multiple wavelengths. For this purpose, the TR system was expanded to 
three pulsed lasers, and time multiplexing was used to acquire the corresponding three 
TPSFs within the same time window (Contini et al., 2006). The disadvantage of this 
approach is a lower count rate per channel due to the reduced pulse repetition rate (29.3 
compared to 80 MHz); however, for steady-state oxygenation measurements this was not 
a concern as the SNR can be improved by increasing the integration time. To quantify the 
wavelength-dependent µa and µ́s values, the IRF was measured for each laser at similar 
count rates to those obtained experimentally. Temporal drift and variations in the laser 
pulse width (i.e. jitter) are potential sources of error when measuring tissue optical 
properties by TR NIRS (Ntziachristos & Chance, 2001). To minimize the former, every 
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experiment was preceded by a 1.5 h delay to allow sufficient time for the TR NIRS 
system to stabilize in order to avoid instrument drift during the course of an experiment 
(Diop, Tichauer, Elliott, Migueis, & Lee, 2010). The results displayed in Figure 2-6 
indicate that the baseline µa and µś values could be determined with reasonable accuracy 
even if there were large fluctuations in the amplitude factor, such as due to jitter. A 
possible improvement to the system would be to correct for both drift and jitter by 
acquiring reference data throughout the experiment (Tichauer et al., 2011). 
The precision of CMRO2 will depend on the uncertainties in the baseline optical 
properties, CBF and ScO2. The Monte Carlo simulations demonstrated that the 
uncertainties in the optical properties were small for noise levels typical of the 
experimental TPSFs and had little effect on subsequent µa values determined from the 
one-parameter fitting routine. These predictions were in good agreement with the SEM of 
ScO2 (0.1%) determined from the series of TPSFs acquired during the 5-min baseline 
period. Errors in CBF determined by the calibrated DCS approach will depend on the 
precision of both the baseline CBF determined by the bolus-tracking method and the 
relative BFI obtained by DCS. From repeat bolus injections at baseline, the precision of 
the former was estimated to be 11.7%, which is similar to the value determined 
previously (9.7%) with a continuous-wave NIRS system (Brown et al., 2002). In these 
experiments, the SEM of the BFI was less than 2% due to the large number of 
acquisitions obtained in each condition. A variability of less than 5% would still have 
been achieved if the acquisition time had been reduced to 5 min (i.e. 10 measurements). 
Maintaining the same precision at shorter acquisitions would require increasing the 
number of detectors (Buckley et al., 2009; Dietsche et al., 2007), as only a single SPCM 
was used to acquire the DCS data in these experiments. In addition to the uncertainties in 
the measurements parameters, the accuracy of the CMRO2 measurements will depend on 
the assumed value of the cerebral venous blood volume fraction (fv). The need to assume 
a value is a common limitation with CMRO2 measurements obtained by NIRS and 
positron emission tomography (Elwell et al., 2005; Mintun, Raichle, Martin, & 
Herscovitch, 1984; Tichauer, Hadway, et al., 2006). The good agreement between the 
NIRS CMRO2 measurements and the values derived from sagittal-sinus blood samples 
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(Figure 2-5) indicate that the assumed value of 75% is reasonable. However, any 
variation in fv across animals or subjects will clearly reduce the accuracy of the 
measurements. It may be possible to circumvent this potential source of error by using 
NIRS spiroximetry to measure venous oxygen saturation (Franceschini et al., 2002). 
The retrieved µ́s values at baseline were similar with Diop et al. and Ijichi et al. 
(Diop et al., 2011; Ijichi et al., 2005)
. 
However, the average µa at 802 nm was greater than 
the values given in the two previous studies: 0.2 ± 0.009 cm-1
 
(Diop et al., 2011) and 
0.189 ± 0.005 (Ijichi et al., 2005). The cause of this difference is uncertain; however, the 
average ScO2 value (69 ± 2 %) was similar to baseline values previously reported in 
piglets (Fantini et al., 1999; Kurth, McCann, Wu, Miles, & Loepke, 2009; Kusaka et al., 
2002; Springett, Newman, Cope, & Delpy, 2000). In addition, the SvO2 values 
determined from the absorption changes at the different metabolic conditions ranging 
from 25 to 70% were in good agreement with the corresponding SvO2 values measured 
directly from sagittal sinus blood samples (Table 2-2, Figure 2-4). Both sets displayed the 
same trend in venous oxygenation as cerebral metabolism was initially increased under 
fentanyl/N2O anesthesia and subsequently decreased with successive injections of 
pentobarbital. 
The overall agreement between CMRO2 measurements derived from TR NIRS 
and sagittal sinus SvO2 values is similar to our previous validation study, which was 
conducted using newborn piglets, but involved a broadband CW NIRS system (Tichauer, 
Hadway, et al., 2006). In that study, the mean difference between the two techniques was 
0.006 ml O2/100g/min and the 95% confidence interval was ± 0.74 ml O2/100g/min. The 
latter is slightly smaller than the boundaries shown in Figure 2-5. However, this 
difference can be explained by the outlier that had an average CMRO2 difference greater 
than the 95% confidence interval. Removing this point reduced the range to ± 0.704 ml 
O2/100g/min, in excellent agreement with the previous results. It is interesting that the 
overall trends reported in the two studies were in good agreement considering the 
different approaches used to quantify cerebral blood oxygenation. The CW NIRS spectral 
data from the previous study were characterized by second derivative spectroscopy, 
which can only estimate [Hb] and not [HbO2] since the latter has no definitive features in 
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the derivative spectrum (Matcher, Cope, & Delpy, 1993). Consequently, CMRO2 was 
determined by normalizing [Hb] by the cerebral blood volume. This step is not required 
for TR NIRS since both [Hb] and [HbO2] are determined from the measured optical 
properties. A further advantage to directly measuring µa and µ́s by TR NIRS is these 
values can also be used in the analysis of DCS data rather than assuming known values. 
Another advantage with TR NIRS is its superior depth sensitivity, which could prove 
useful when adapting these optical technologies to measuring CBF and CMRO2 in adult 
patients (Elliott, Diop, Tichauer, Lee, & St. Lawrence, 2010; Liebert, Wabnitz, 
Steinbrink, Obrig, & Mo, 2004). 
Although both studies demonstrate similar agreements between the NIRS and 
sagittal sinus CMRO2 measurements, there was a large difference in the initial baseline 
CMRO2 values between the two studies: 1.48 ± 0.17 ml O2/100g/min in the current study 
and 2.60 ± 0.28 ml O2/100g/min from Tichauer et al. (Tichauer, Hadway, et al., 2006). 
One possible explanation is the difference in baseline anesthetics in the two studies. 
Baseline measurements in the current study were acquired using a higher concentration of 
isoflurane (1.75-2% compared to 1.5%), which will reduce cerebral energy metabolism. 
Another contributing factor could be the difference in CBF measurements from CW and 
TR NIRS techniques. Previously, we have demonstrated that the CBF values from TR 
NIRS underestimated the CW NIRS values, although the reason for this difference was 
unclear (Diop, Tichauer, Elliott, Migueis, Lee, et al., 2010). Adjusting the current 
CMRO2 values for this difference would increase the mean baseline value to 2.00 ± 0.22 
ml O2/100g/min, which is still below our previous results. Most likely, the overall 
difference between the two studies is a combination of both factors.  
In addition to the different anesthetics, measurements were also conducted after 
administering sodium cyanide. This drug was used to alter cerebral oxidative metabolism 
by an alternative means, namely, the inhibition of mitochondrial cytochrome oxidase. 
Overall, the agreement between the DCS/TR-NIRS and sagittal sinus CMRO2 values 
under this condition was similar to that observed under the different anesthetics. 
However, the metabolic effect of cyanide was smaller than expected based on a previous 
study involving newborn piglets (C. Cooper et al., 1999). This muted effect is likely a 
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result of injecting the sodium cyanide while the animals were under the deepest 
anesthetic (pentobarbital plus isoflurane). Nevertheless, cyanide did cause a small 
reduction in CMRO2, which was observable by both techniques. 
A potential limitation with the current study is that the CBF measurements 
obtained by the calibrated DCS technique were used to convert both the sagittal-sinus and 
NIRS venous oxygenation measurements into CMRO2. Consequently, any systemic error 
in the optical CBF measurements would not be observed in this study. We previously 
demonstrated a very strong correlation between relative flow changes measured by DCS 
and CBF values measured by TR NIRS with a slope from the linear regression of 1.05 
(Diop et al., 2011). This comparison was conducted over a range of CBF values from 17 
to 90 ml/100g/min, which is very similar to the range observed in the current study. 
However, more validation studies would be required if the combined DCS/TR-NIRS 
approach were used to measure CMRO2 under pathological conditions such as during 
ischemia or severe hypoxia that could result in greater changes in either CBF or SvO2 
(Ijichi et al., 2005; Tichauer, Brown, et al., 2006).  
2.5 Conclusion 
In summary, this study demonstrated that the combination of DCS and TR NIRS can be 
used to measure CMRO2, as verified by the comparison to CMRO2 values derived from 
cerebral venous blood samples. Experiments were conducted using piglets because they 
are similar in size to human newborns and, therefore, the DCS/TR-NIRS system could be 
used in clinical studies. Adapting this approach to the neonatal intensive care unit will 
require synchronizing the two optical systems to provide truly continuous CBF and 
CMRO2 measurements. Extending this approach to adult patients represents a significant 
challenge as it requires depth-resolved techniques, such as the use of multi-layered 
modeling approaches, to measure CBF, cerebral oxygenation and the BFI accurately 
(Gagnon, Desjardins, Jehanne-Lacasse, Bherer, & Lesage, 2008; Jaillon et al., 2006; 
Wabnitz et al., 2010). Incorporating sensitivity functions for the different tissue layers 
into the analysis of bolus tracking data has been shown to improve the accuracy of CBF 
measurements in animal models; however, clinical studies will require validating this 
approach in human subjects (Elliott, Diop, Lee, & Lawrence, 2012; Elliott et al., 2010). 
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Chapter 3  
3 Measurements of Cerebral Blood Flow in Pigs by 
Diffuse Correlation Spectroscopy on the Exposed 
Cortex 
This chapter is adapted from the paper entitled “Assessment of the best flow model to 
characterize diffuse correlation spectroscopy data acquired directly on the brain” by 
Verdecchia K, Diop M, Morrison L, Lee T-Y, St. Lawrence K, published in Biomedical 
Optics Express, vol. 6(11) pp. 4288-4301 (2015). 
3.1 Introduction 
Near-infrared spectroscopy (NIRS) methods based on the quantification of light 
absorption at specific wavelengths have been developed for measuring key physiological 
parameters, such as tissue perfusion, blood volume and oxygenation (Boas & 
Franceschini, 2011; Durduran & Yodh, 2014; Mesquita et al., 2011). For example, blood 
flow can be measured by manipulating arterial oxygenation saturation or injecting a light-
absorbing contrast agent (Diop, Verdecchia, Lee, & St Lawrence, 2011; Kyle Verdecchia, 
Diop, Lee, & St. Lawrence, 2013; Weigl et al., 2014); however, these techniques only 
enable single time-point measurements. An alternative approach that provides continuous 
blood flow monitoring is diffuse correlation spectroscopy (DCS) (Durduran & Yodh, 
2014). This method indirectly measures changes in blood flow by monitoring light 
intensity fluctuations caused by the movement of erythrocytes in tissue (Boas, Campbell, 
& Yodh, 1995; Ninck, Untenberger, & Gisler, 2010). More specifically, the propagation 
of photons through extravascular tissue, where they endure multiple scattering events that 
randomize their direction, and within vessels, which contain moving erythrocytes, 
induces decorrelation of the light that manifests as intensity fluctuations. Blood flow is 
assessed by characterizing light intensity decorrelation using a model that describes the 
movement of erythrocytes. 
Currently, the most common approach for analyzing DCS data is by modeling 
erythrocyte motion as a Brownian diffusion-like process, which has previously been 
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shown in various species (swine, rodent and human) to provide a better characterization 
of the normalized temporal intensity autocorrelation function than the expected random 
flow model (RFM) (Binzoni & Martelli, 2015), which describes the motion of erythrocytes 
as ballistic (Carp, Dai, Boas, Franceschini, & Kim, 2010; Diop et al., 2011; Kim et al., 
2010; Yu et al., 2007; Zhou et al., 2007). To explain this unexpected finding, Carp et al. 
proposed a hybrid model, referred to as the hydrodynamic diffusion model (HDM), that 
accounts for both the possibility of multiple light-scattering events within a vessel, 
characteristic of diffusive motion, and light-scattering events across vessels, 
characteristic of random ballistic motion (Carp et al., 2011). Furthermore, Carp et al. 
demonstrated that the DCS measurements are best fit by the HDM for data acquired on 
premature newborns (Carp et al., 2011). 
Although DCS has been shown to be a promising tool for blood flow monitoring, 
the most appropriate flow model for characterizing perfusion is still debatable. The 
purpose of the current study was to compare the ability of the three flow models to 
characterize DCS data acquired directly on the exposed cerebral cortex of juvenile pigs. 
This approach removes signal contributions from the extracerebral tissues (scalp and 
skull) that can alter the shape of DCS autocorrelation curves due to partial volume errors 
caused by tissue heterogeneity (Gagnon, Desjardins, Jehanne-Lacasse, Bherer, & Lesage, 
2008). In addition, cerebral blood flow (CBF) was independently measured by computed 
tomography perfusion (CTP) for comparison to the flow estimates obtained by each of 
the three flow models. 
3.1.1 Diffuse Correlation Spectroscopy 
To assess dynamics of light scatterers, DCS measures the normalized intensity 
autocorrelation function, g2(ρ,τ) given by (Cheung, Culver, Takahashi, Greenberg, & 
Yodh, 2001): 
g>ρ, τ ≡ 〈V,V,;W〉〈V,〉F     (3.1) 
82 
 
where <I> , ρ and τ represents the average detected intensity, the source-detector distance 
(SDD) and the correlation time, respectively. Equation 3.2 is related to the electric field 
autocorrelation function by the Siegert relation (Lemieux & Durian, 1999): 
g>ρ, τ = 1 + β |[\,|2〈V,〉F      (3.2) 
where, β is the coherence factor of the detection channel and G1(ρ,τ) is the electric field 
autocorrelation function. Previously shown, G1(ρ,τ) satisfies a diffusion equation (Boas et 
al., 1995; Boas & Yodh, 1997). Assuming a point light source with unit intensity, the 
analytical solution to the correlation diffusion equation for a semi-infinite homogeneous 
medium is given by (Cheung et al., 2001; Diop et al., 2011; Durduran, Choe, Baker, & 
Yodh, 2010): 
Gρ, τ = 39:/0 bcde
f5\
5\ −
cdef5\
5F g    (3.3) 
Where, r1 = [ρ2+(z0)2]1/2, r2 = [ρ2+(z0+2zb)2]1/2, zb is the effective depth of the source, and 
zb = 2D(1+Reff)/(1-Reff) is the distance above the tissue surface at which the fluence 
vanishes, where D is the diffusion coefficient given as (3µ s')-1 and Reff is the effective 
reflection coefficient calculated to be 0.493 for the refraction indices of tissue and air 
(Haskell et al., 1994). Furthermore, in Equation 3.3, µD is given by: 
μ4> τ = 3`4 μ
 + αμk>〈rτ〉            (3.4) 
The coefficients µa and µś are the absorption and reduced scattering coefficient, 
respectively, k0 is the wavenumber of light in the medium, α is the proportion of moving 
scatters (predominantly red blood cells) to all scatterers and is related to the blood 
volume, and <∆r2(τ)> is the mean-square displacement of the moving scatterers during a 
correlation time τ. In the analysis of measured g2(ρ,τ), the specific expression for 
<∆r2(τ)> is given by one of the following flow models. 
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3.1.2 Random Flow Model 
The RFM is based on the assumption that photon scattering events associated with motion 
occur from scatterers that are uncorrelated (i.e. in separate vessels). In this case, the 
mean-square displacement is given by: 
〈Δr>τ〉 = V>τ>     (3.5) 
where, V is the velocity of the moving erythrocytes. The product αV2 is referred to as the 
random blood flow index (BFIR). 
3.1.3 Brownian Diffusion Model 
The Brownian diffusion model (BDM) assumes incoherent motion caused by multiple 
interactions of moving scatterers, such as erythrocytes within the same vessel. It is the 
most commonly used model in DCS analysis and the Brownian displacement formula is 
given by: 
〈Δr>τ〉 = 6Djτ     (3.6) 
where, DB is the effective diffusion coefficient, and αDB is referred to as the Brownian 
blood flow index (BFIB). 
3.1.4 Hydrodynamic Diffusion Model 
Carp et al. proposed using the Langevin formula for red blood cell mean squared 
displacement to account for the occurrence of both Brownian and random flow motion 
(Carp et al., 2011): 
〈Δr>τ〉 = 6DC τ − τy b1 − exp =− WWl@g    (3.7) 
required to establish diffusive motion. Unlike the Brownian diffusion model, τc accounts 
for possible ballistic motion at short delay times. For the HDM, the two fitting parameters 
are τc and αDH, the hydrodynamic blood flow index (BFIH). 
84 
 
3.2 Methods 
3.2.1 Experimental Procedure 
Animal experiments were conducted in accordance with the guidelines of the Canadian 
Council of Animal Care (CCAC) and approved by the Animal Use Committee at Western 
University. Juvenile pigs (~6 weeks old) were obtained from a local supplier on the day 
of the experiment. Following anesthetic induction with 5% isoflurane, the animals were 
tracheotomized and mechanically ventilated on a mixture of oxygen and medical air. A 
catheter was inserted into a femoral artery for blood gas analysis. After surgery, the 
isoflurane was reduced to 3-4% and the animal was transported to the computed 
tomography (CT) suite where the experiments were conducted using a portable 
NIRS/DCS system. 
The animal was placed prone on the bed of the CT scanner on top of a heated 
blanket used to maintain rectal temperature between 38 and 39 ºC throughout the 
experiment. To place the optical probes directly on the brain, a rectangular piece of scalp 
tissue (~10 cm2) located laterally to the midline on the right hemisphere was first excised. 
A caustic pencil was used to cauterize the incised scalp tissue to prevent bleeding. Lastly, 
a handheld dremel was used to drill two burr holes, which were the size of optical fibers, 
into the skull parallel to the midline. Care was taken to ensure that the dura mater was not 
punctured by the dremel. Contact pressure on the dura was minimized since the fibers fit 
tightly in the holes, which carried their weight. Furthermore, the distance to the dura 
could be measured on the CT images (Figure 3-1) and used to guide the distance that the 
fibers were inserted. The burr holes were 7 mm apart, with the exception of one animal 
for which the separation was 20 mm. A scout CT scan with an anatomical marker on top 
of the skull was used to define the location of the burr holes. 
Following surgery, the emission and detection fibers were placed in the posterior 
and anterior burr holes, respectively. The head of the pig was covered by an opaque 
blanket to reduce ambient light contamination. During the experiment, arterial oxygen 
saturation, heart and respiration rates, mean arterial pressure, and rectal temperature were 
continuously monitored. Arterial blood samples were obtained to measure arterial pH, 
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partial carbon dioxide tension (paCO2), partial oxygen tension (paO2) and blood glucose 
(BG) concentration. Samples were acquired before and after each set of measurements to 
assess physiological stability during the data acquisition period. Intermittent dextrose 
injections were administered to maintain normal BG levels (between 5 and 7 mmol/L). 
Two sets of CT, time-resolved (TR) NIRS, and DCS data were acquired in each 
experiment: first at normocapnia (paCO2 between 38 and 42 mmHg) and then at 
hypocapnia (paCO2 between 20 and 25 mmHg). Each capnic level was maintained by 
adjusting the ventilation volume and rate. The sequence of data acquisition during 
normocapnia consisted of CT perfusion, TR NIRS measurements of optical properties 
and DCS. For the hypocapnic condition the sequence of data acquisition was reversed in 
order to avoid removing the optical probes from the burr holes between the two 
conditions. 
3.2.2 Computed Tomography 
The dynamic CT protocol consisted of a bolus injection of 1.0 mL/kg of iodine-based 
contrast agent (iopamidol [370-Isovue®], Bracco S.p.A., Milan, Italy) at a rate of 3 mL/s 
into the cephalic vein once during each capnic condition. The first five animals were 
scanned by a Lightspeed QXi multislice scanner (General Electric Company, Waukesha, 
WI) and the last three animals were scanned by the Revolution CT scanner (General 
Electric Company, Waukesha, WI) due to scanner availability. Each scan (slice thickness 
= 2.5 mm, current = 200 mA, energy = 80 kVp, FOV=140×140×40 mm) provided sixteen 
coronal slices, once every second, for a period of 40 s. The field of view covered the 
entire head of the pig. Functional maps of CBF were calculated using the clinical CT 
perfusion software package (PERFUSION 5, General Electric Healthcare Worldwide), 
which was developed and validated in house (Cenic, Nabavi, Craen, Gelb, & Lee, 1999). 
Region of interest (ROI) analysis was performed using an in-house developed software 
that performed pixel thresholding to remove signal contributions from large vessels that 
can lead to overestimation of CBF (Murphy et al., 2006). Five sequential slices between 
the burr holes that were visible on the anatomical CT images were chosen as they 
correspond to the “banana-shaped” path of the near-infrared light between the emission 
and detection optical fibers, as seen in Figure 3-1. For each slice, an ROI (~5 cm 
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diameter) was drawn on the cerebral cortex near the skull, since NIRS is most sensitive to 
superficial tissue. The CBF values were obtained by averaging over the ROIs in the five 
slices. 
 
Figure 3-1: Single slice of the exposed cortex of a pig: perfusion map and anatomical 
CT images 
A CT image of a single slice for a blood flow map (A) and the corresponding anatomical map (B). The ROI, 
shown in black for A and white for B, was manually drawn on the superficial cortex using in-house software. 
The burr hole, which exposed the cortex and held the optical fiber, is identified by the white arrow.  
3.2.3 Optical Methods 
3.2.3.1 Time-Resolved NIRS 
The TR NIRS systems consisted of a picosecond pulsed diode laser (LDH-P-C 764, 
PicoQuant, Germany) emitting at 764 nm, with an average output power and pulse 
repetition rate of 1.4 mW and 80 MHz, respectively. The light was attenuated using 
electronically controlled variable neutral density filters (NDC-50C-4M, Thorlabs) and 
coupled to a multimode emission fiber used for both DCS and TR NIRS (emission probe: 
N.A. = 0.22, core = 400 µm; Fiberoptics Technology, Pomfret, CT). A 2-m fiber (N.A. = 
0.22, core = 400 µm; Fiberoptics Technology, Pomfret, CT) was used to detect light at a 
SDD of 7-mm. The TR NIRS detection fiber was coupled to a fast hybrid photomultiplier 
detector with Peltier cooling (PMA Hybrid, PicoQuant, Germany). The output of the 
detector was sent to a multichannel picosecond event timer and time-correlated single-
photon counting (TCSPC) module (HydraHarp 400, PicoQuant, Germany). The system 
was given at least a 2-hour warmup period to stabilize the laser and detection system 
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before acquiring data (Verdecchia, Diop, Lee, & St. Lawrence, 2015). Under each capnic 
condition, a distribution of times of flight of photons (DTOF) was recorded for 30 
seconds. At the end of the study, the instrument response function (IRF) was measured to 
account for systemic temporal dispersion (Ntziachristos & Chance, 2001). 
Tissue optical properties (µa and µś) were acquired for each condition to reduce 
inter-subject variability when extracting blood flow indices from DCS (Diop et al., 2011; 
Irwin et al., 2011). A three-parameter fitting routine, described in detail elsewhere (Diop 
et al., 2010), was used to extract estimates of µa,	µ́s and an amplitude scaling factor during 
normocapnia. The model used to fit the DTOF was the solution of the diffusion 
approximation for a semi-infinite homogeneous medium convolved with the measured 
IRF. The short SDD was calibrated with a phantom of known optical properties. The 
fitting range was set to 95% and 30% of the peak DTOF value for the ascending and 
descending sides, respectively. The measured µ́s for normocapnia was fixed when 
analyzing the DTOF acquired during hypocapnia to reduce the number of fitting 
parameters to µa and amplitude scaling factor. 
3.2.3.2 Diffuse Correlation Spectroscopy 
The light source of the DCS system consisted of a continuous-wave laser (DL785-100-S, 
CrystalLaser, Nevada) emitting at 785 nm with a maximum output power of 100 mW and 
a coherence length >5 m. As with the TR NIRS system, the emitted light was attenuated 
by electronically controlled variable neutral density filters and coupled to the multimode 
emission fiber. A single-mode fiber (SMF-28e+, N.A. = 0.14, length = 4 m, core = 8.2 
µm, single-mode cutoff wavelength at 1260 nm) was placed in the anterior burr hole of 
the animal and was used for detecting the temporal light intensity fluctuations. The SMF 
was tightly wrapped into a 5-cm coil to increase the losses of the higher-order modes 
before being coupled to the input-channel of the avalanche photodiode of a single photon 
counting module (SPCM-AQ4C, Excelitas Canada Inc, QC, Canada) (Dietsche et al., 
2007; Gisler et al., 1995). The output of the SPCM was sent to a photon correlator board 
(DPC-230, Beker & Hickl, Germany) that computed the normalized intensity 
autocorrelation functions (g2). 
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For each animal, two g2 curves were acquired, one during normocapnia and one 
during hypocapnia, over an acquisition period of 90 s. The µa and µ́s measured by TR 
NIRS were used in the DCS fitting routine. Each g2 curve was analyzed three times using 
the solution of the diffusion approximation for a semi-infinite homogeneous medium 
including one of the three flow models (BDM, RFM and HDM). The start and end limits for 
the fitting were defined by correlation times of 0.6 µs and 1 ms, respectively. In the 
fitting procedure, the coherence factor β was set to the value determined by averaging the 
first 10 data points of each g2 curve. 
3.2.4 Statistical Analysis 
All errors are given as the standard errors of the mean (SEM), unless stated otherwise. 
All statistics were computed with the IBM SPSS Statistics 20 software package. For the 
measured physiological parameters, a multivariate analysis of variance (ANOVA), which 
included pH, paCO2, paO2, cGlu, ctHb, MAP, HR, temperature, and SpO2, was computed 
to determine significant changes between capnic conditions. For two experiments, the TR 
NIRS data set was not experimentally collected due to overheating of the detector and 
therefore were determined by the average optical properties of the remaining animals 
during normocapnia. For the hypocapnia optical properties, the µa values were estimated 
from the average change in absorption from normocapnia to hypocapnia measured by all 
animals in this study. A one-way ANOVA compared capnic conditions for measured µa 
and BFI values, and, for the former, a post-hoc test [Tukey’s honest significant difference 
(HSD)] identified any significant light absorbing outliers between subjects. 
A direct comparison between the sums of squares (SS) determined the best fit of 
the BDM and RFM, since both models included one fitting parameter. However, the extra 
fitting parameter (τc) included in the HDM is expected to reduce the variance in the fit of 
the measured g2(ρ,τ). Therefore, an F-test was used to compare whether the 
improvements by the HDM to fit the measured g2(ρ,τ) curves, due to the additional fitting 
parameter, exceeded the reduction in variance similarly to the approach used by Carp et 
al. (Carp et al., 2011). The degree of freedom used in the F-test was determined by the 
number of correlation bins that the individual fit required, which was 164. For the HDM to 
better characterize the data compared to either the BDM or the RFM, the calculated F-
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number had to exceed a critical F-value of 3.9, as determined by the finv function in 
MATLAB (Mathworks, Natick, MA) for a p<0.05. 
Linear regression analysis was performed to assess the correlation between CBF 
measured by CTP, and the blood flow index obtained by each of the three DCS models 
and τc for the HDM. A Bland-Altman plot was used to assess the difference in the percent 
flow reductions measured by DCS and CTP (Altman & Bland, 1983). For the Bland-
Altman plot, a one-sample t-test identified differences between the two modalities (DCS 
and CTP), and a linear regression was used to determine any proportionality bias. 
3.3 Results 
3.3.1 Physiological Parameters and Optical Properties 
Eleven juvenile pigs (ten females, one male) were used in the study with an average 
weight of 16.0 ± 0.7 kg; however, only nine animals were scanned by CTP due to limited 
access to the CT scanner for the first two experiments. 
Table 3-1: Physiological parameters during normocapnia and hypocapnia 
Condition *pH 
*paCO2  
[mmHg] 
paO2 
[mmHg] 
ctHb 
[g/dL] 
MAP 
[mmHg] 
HR 
[bpm] 
Normocapnia 7.45 ± 0.01 40.2 ± 0.3 182 ± 11 10.2 ± 0.3 43.6 ± 1.9 128 ± 8 
Hypocapnia 7.62 ± 0.02 22.1 ± 0.4 213 ± 12 9.8 ± 0.4 38.1 ± 1.9 121 ± 7 
Note: Data are presented as average ± SEM. paCO2, partial pressure of carbon dioxide in the blood; paO2, 
partial pressure of oxygen in the blood; MAP, mean arterial blood pressure; HR, heart rate. 
* p<0.05 between conditions. 
Table 3-1 lists the physiological parameters measured during normocapnia and 
hypocapnia. A multivariate ANOVA indicated significant differences between capnic 
conditions for blood pH [p<0.001, partial-η2=0.84, power=1.00] and arterial carbon 
dioxide pressure (paCO2) [p<0.001, partial-η2=0.98, power=1.00] as expected. All other 
physiological parameters, including BG concentration, temperature and arterial oxygen 
saturation, did not change. Their mean values were 4.0 ± 0.2 mmol/L, 38.4 ± 0.1 º°C, and 
95 ± 1%, respectively. 
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Figure 3-2: Tissue absorption measured by TR NIRS directly on the brain 
Average µa values for the 10 animals included in this study and the µa value of the excluded outlier. 
Absorption values are presented for normocapnic (black) and hypocapnic (grey) conditions. The large µa for 
the outlier was attributed to excessive blood in the emission burr hole. Error bars represent the SEM. 
Figure 3-2 presents the average µa values measured by TR NIRS during 
normocapnia and hypocapnia. No significant difference between the two conditions was 
observed [p>0.55, partial-η2=0.02, power=0.09]. Following surgery, visible 
hemorrhaging in the emission burr hole was observed in one animal, which resulted in 
high µa values, as confirmed by a Tukey HSD post-hoc analysis (Figure 3-2). 
Consequently, the data from this animal were removed from further analysis, unless 
stated otherwise. The mean µ́s for all animals was 10.7 ± 1.3 cm-1. 
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Figure 3-3: Hemodynamics measured by CTP and DCS during normocapnia and 
hypocapnia 
Measured flow by (A) CTP (N = 9) and (B) DCS using the BDM (N = 10), during normocapnia and 
hypocapnia. The line of best fit and CI95% are represented by the dashed red line and blue lines, 
respectively. 
Figure 3-3 presents CBF values measured by CTP and the BFIB derived from the 
DCS data, both plotted as a function of paCO2. The outlier identified in Figure 3-2 was 
excluded from the DCS data. The results from the BDM are presented since it is the model 
most commonly used to analyze DCS data. Regression analysis resulted in a slope of 1.4 
± 0.20 mL/min/100g/mmHg (CI95%: 0.94, 1.8, p<0.001), an intercept of 7.1 ± 6.6 
mL/min/100g (CI95%: -6.8, 21.1, p>0.29) and correlation coefficient (R) of 0.86 for CBF 
versus paCO2. Likewise, the line of best fit from Figure 3-3B had a slope of (1.2 ± 0.3) x 
10-9 cm2/s/mmHg [CI95%: (0.45, 1.86) x 10-9, p<0.003], an intercept of (1.7 ± 10.9) x 10-9 
cm2/s [CI95%: (-21.2, 24.6) x 10-9, p>0.88] and R of 0.63. 
Table 3-2 lists the mean CBF values measured by CTP and corresponding BFI 
values derived from the DCS data using each of the three flow models. All values (CBF, 
BFIB, BFIR and BFIH) were significantly different (p<0.05) between the two capnic 
conditions. 
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Table 3-2: Hemodynamic parameters measured by CTP and DCS during 
normocapnia and hypocapnia 
Condition 
*CBF 
[mL/min/100g] 
*BFIB 
[10-9 cm2/s] 
*BFIR 
[10-3 cm2/s] 
*BFIH 
[10-9 cm2/s] 
*τc 
[µs] 
Normocapnia 62.5 ± 2.5 47.6 ± 4.9 37.2 ± 8.0 70.0 ± 8.2 2.72 ± 0.34 
Hypocapnia 37.7 ± 2.6 27.9 ± 4.1 12.5 ± 3.3 38.2 ± 6.4 3.52 ± 0.29 
Note: Values represent the average ± SEM. CBF, cerebral blood flow quantified by CTP; BFIB, blood flow 
index determined by the Brownian flow model; BFIR, blood flow index determined by the random flow model; 
BFIH, blood flow index determined by the hydrodynamic flow model; τy, the time scale for the randomization 
of velocity vectors associated with RBC scattering events.  
* p<0.05 between conditions. 
Included in Table 3-2 is τc from the HDM, which was also significantly different 
(p<0.05) between conditions. Not given in Table 3-2 are the average value of β, which 
was 0.152 ± 0.002 for all models; no significant differences were observed between 
capnic conditions. 
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3.3.2 Example of the Best-Fit of the Flow Models 
Figure 3-4 shows normalized intensity autocorrelation curves obtained on the exposed 
cerebral cortex of one animal during normocapnia (blue) and hypocapnia (red).  
 
Figure 3-4: Measured DCS decay curves acquired during normocapnia and 
hypocapnia 
DCS autocorrelation curves during normocapnia (red dots) and hypocapnia (blue dots) from one animal. 
Also shown are the best-fit to the three DCS flow models: BFIB (solid line), BFIR (dotted line) and BFIH 
(dashed line). Data were acquired with a count rate of ~600 kHz for a total acquisition time of 30 seconds. 
To visually enhance the differences between the fits of the three models, a portion of the graph is displayed 
that focuses on correlation times between 2 to 12 µs, which encompass the initial decay of the measured 
intensity autocorrelation functions.  
The normalized intensity autocorrelation curves decayed faster during 
normocapnia than during hypocapnia, reflecting the higher blood flow in the former 
condition. For the example shown in Figure 3-4, the blood flow reductions measured by 
BFIB, BFIR and BFIH were 48.9%, 74.0% and 50.0%, respectively. Figure 3-4 illustrates 
the poor fit of the RFM model. A statistical analysis by the F-test, as was described earlier, 
indicated that the fit of the HDM was significantly better than for the BDM for all 
autocorrelation curves. No differences were observed in the extracted BFI values by 
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including more of the tail component of the correlation curves in the fitting routine (data 
not shown). 
To further investigate the fits of the three DCS flow models, Figure 3-5 presents 
continuous BFI values during the transition from normocapnia to hypocapnia. The BFI 
was determined from autocorrelation curves generated every two seconds. The flow 
reductions measured by the three models were 34.1%, 54.6% and 34.6% for the BDM, 
RFM and HDM, respectively. 
 
Figure 3-5: Real-time change of BFI measured during the transition from 
normocapnia to hypocapnia directly on the brain 
Real-time change in BFI measured during the transition from normocapnia to hypocapnia in one pig. DCS 
data were acquired at a count rate of 780 ± 3 kHz and analyzed by each flow model. The dashed line 
represents the end of the normocapnic period before the respirator was adjusted to induce hypocapnia. 
3.3.3 Computed Tomography Perfusion Comparison 
Linear regression between the CBF change measured by CTP and the corresponding BFI 
change measured by each of the three DCS models was conducted on eight experiments 
after the outlier was removed (Figure 3-2). Also, linear regression between the CBF 
change measured by CTP and τc was conducted. The resulting regression slopes, 
intercepts and R-values are listed in Table 3-3. 
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Table 3-3: Linear relationship between CTP and corresponding DCS indices from 
different flow models 
Parameter Units Slope (CI95%) Intercept (CI95%) R-value 
BFIB cm2/s *1.03 ± 0.23 (0.54, 1.52)  -13.9 ± 12.1 (-39.9, 12.1) 0.78 
BFIR cm2/s *1.24 ± 0.33 (0.52, 1.95) -36.8 ± 17.7 (-74.8, 1.1) 0.70 
BFIH cm2/s *1.66 ± 0.36 (0.89, 2.44) -27.9 ± 19.1 (-68.9, 13.0) 0.78 
τc µs *-0.030 ± 0.015 (-0.061, -0.001)  *4.86 ± 0.76 (3.24, 6.48)  0.46 
Note: BFIB, blood flow index determined by the DCS Brownian flow model; BFIR, blood flow index 
determined by the DCS random flow model; BFIH, blood flow index determined by the DCS hydrodynamic 
flow model; CI95%, 95% confidence intervals. Estimated slope and intercept (± SEM) for linear regression 
between CTP and BFI for each flow model along with the correlation coefficient (R) and p-values calculated 
by SPSS. * represents coefficients that are significantly different (p<0.05) from the null. 
Table 3-3 demonstrates that the BFI values from each of the three models were 
correlated with CBF measured by CTP as indicated by a slope significantly different 
(p<0.01) from the null but a y-intercept not significantly different from zero. The 
displacement time constant τc, from the HDM also correlated with CBF, but its R-value 
was not as strong and the y-intercept was significantly different from the zero. 
Figure 3-6 presents the relative CBF decrease from normocapnia to hypocapnia as 
measured by CTP and DCS. The box-plot presents the results from all three DCS flow 
models, whereas only the results from the BDM are presented in the Bland-Altman plot. In 
Figure 3-6A, the average CBF change measured by CTP was -39.7 ± 3.7%, which was 
only significantly different from the change in BFIR (-63.2 ± 4.7%) and not from the BFI 
changes measured by the other two models (-41.0 ± 4.3% for BFIB and -44.2 ± 5.0% for 
BFIH). In Figure 3-6B, the mean difference between BFIB and CTP, indicated by the solid 
line, was 9.0 ± 5.1%, which was not significant (CI95%: -19.1 and 37.0, as indicated by 
the two solid lines). 
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Figure 3-6: Comparison between the percent difference of CBF measured by CTP 
and different DCS flow models acquired on the exposed cortex of pigs 
Flow percent differences measured by CTP and DCS directly on exposed cortical tissue. (A) Box plots of the 
reductions in flow from normocapnia to hypocapnia measured by CTP (N = 9) and the three DCS flow 
models (N = 10). The center line, box edges, error bars, and the cross represents the median, 1st and 3rd 
quartiles, CI95%, and outliers, respectively. (B) Bland-Altman plot comparing the reductions in CBF measured 
by CTP and BFIB (N = 8). Each symbol represents a single animal. The mean difference between the two 
modalities, the standard error of the mean, and the CI95% are indicated by the solid line, the dotted line and 
the dashed line, respectively. 
In Figure 3-6B the animals that did not undergo CTP and the optical outlier for 
DCS were removed due to listwise deletion. For clarity, Table 3-4 summarizes all of the 
pigs in this study with their acquired modalities (CTP, TR NIRS and DCS) and SDD. 
Table 3-4: A summary of all animals with acquired modalities. 
Animal Number CTP TR NIRS DCS SDD [mm] 
1 No Yes Yes 7 
2 No Yes Yes 7 
3 Yes No (Unstable System) Yes 7 
4 Yes No (Unstable System) Yes 7 
5 Yes Yes Yes 7 
6 Yes Yes Yes 20 
7 Yes Yes Yes 7 
8* Yes Yes Yes 7 
9˟ Yes Yes Yes 7 
10 Yes Yes (Identified Outlier) Yes (Removed Outlier) 7 
11^ Yes Yes Yes 7 
Note: ˟, * and ^ represents the animal used in Figure 3-1, Figure 3-4 and Figure 3-5, respectively. An 
unstable TR NIRS system occurred by an overheated detector prior to acquisitions. The identified outlier 
was described in detail above by Figure 3-2. 
97 
 
3.4 Discussion 
The main aims of this study were to assess which DCS flow model best characterized 
‘brain’ autocorrelation curves and to compare measured flow reductions obtained with 
the different models to an independent measure of CBF. These experiments were 
conducted with the optical probes placed directly on the exposed cortex in order to collect 
DCS data without any signal contamination from extracerebral tissues. To verify that the 
interrogated cortical region was relatively homogeneous with regards to blood flow, the 
autocorrelation curves were re-analyzed using only the early portion (i.e. between 
correlation times of 0.3 and ~10 µs) since this range is considered more sensitive to 
deeper propagating photons (Selb et al., 2014). No significant differences in blood flow 
indices were observed compared to the larger range of correlation times (0.6 µs to 1 ms) 
used in the Methods section, indicating that it was reasonable to consider the exposed 
cerebral cortex as a homogeneous medium (Verdecchia, Diop, & St. Lawrence, 2015). 
Of the three models used to characterize normalized intensity autocorrelation 
functions, the hybrid model, HDM, which accounts for both diffusive and ballistic motion, 
provided the best fit as determined by the F-test. This was evident at early correction 
times, which represents the transition from the ballistic to diffusion regime (Figure 3-4). 
This finding is in agreement with Carp et al., who found that the HDM provided a superior 
fit to DCS data acquired from premature infants (Carp et al., 2011). The additional 
constant τc, which represents the time scale to transition from ballistic to diffusive 
motion, was found to be significantly greater (~29%) at hypocapnia compared to 
normocapnia. This inverse relationship with CBF would be expected considering that 
within a given period fewer interactions between RBCs within a vessel would occur as 
flows decreases. Despite the better fit provided by the HDM, differences in blood flow 
indices from this model and the more commonly used BDM were small. No significant 
differences were observed between the two models in terms of absolute BFI values and 
relative changes. This agreement indicates that the ballistic range of photons detected by 
DCS is relatively small, suggesting that most detected photons undergo correlated 
scattering events (i.e. scattering events occurring within a single vessel). 
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A practical limitation with using the HDM is the addition of an extra fitting 
parameter, τc, which leads to a greater sensitivity to noise in the measured autocorrelation 
curves. This was demonstrated visually by the continuous monitoring example shown in 
Figure 3-5, in which data were acquired every two seconds. To characterize the noise 
sensitivity of each model, the coefficient of variation of the BFI over the baseline period 
was computed. The coefficient for BFIH was 38.5% larger than for BFIB. Furthermore, 
the linear regression analysis between the blood flow indices and CBF measurements 
from CTP showed less uncertainty and a tighter confidence interval range for the BDM 
than the HDM (Table 3-3). Therefore, the BDM model, which is more robust and provides 
similar BFI measurements to the HDM, is the more practical model to use, particularly for 
data with a lower signal-to-noise ratio, such as the real-time DCS monitoring displayed in 
Figure 3-5. 
For the second aim of this study, CTP was used to measure CBF at normocapnia 
and hypocapnia. The latter causes a substantial reduction in CBF because of the tight 
coupling between cerebrovascular tone and arterial blood carbon dioxide tension. 
Hypocapnia rather than hypercapnia was used in these experiments because decreases in 
blood flow are clinically relevant to the management of critical care patients due to the 
incidence of delayed cerebral ischemia. Flow reductions caused by hypocapnia are not as 
great as caused by ischemia; however, the good agreement with the CTP results is further 
evidence of the ability of DCS to measure CBF changes accurately. The cerebral vascular 
reactivity measured with the BDM was (-2.3 ± 0.2)% per mmHg of paCO2, which is in 
good agreement with our previous study, which used the same animal model (juvenile 
pigs) and a contrast-enhanced NIRS technique to measure CBF (Elliott et al., 2014). 
Likewise, these findings confirm previous validation studies involving both animal 
models and human subjects that have shown a good correlation between BFIB and CBF 
changes measured by other modalities (Yu et al., 2007; Zhou et al., 2006). Considering 
that the DCS data in the current study were collected directly on the brain, this agreement 
is evidence that DCS is relatively insensitive to extracerebral signal contamination in 
applications in which the scalp and skull are thin. These would include animal models, 
such as piglets and rats (Carp et al., 2010; Diop et al., 2011), but more importantly, also 
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applies to newborns (Diop, Kishimoto, Toronov, Lee, & Lawrence, 2015; Jain et al., 
2014). 
A possible limitation with this study is the potential for CTP to overestimate CBF 
due to the presence of pixels with extremely high flow estimates. These ‘vascular’ pixels 
are attributed to high contrast enhancement in vessels and were removed in the current 
study by setting perfusion thresholds (Murphy et al., 2006). This procedure has been 
shown to significantly improve the correlation with CBF measurements from positron 
emission tomography (Kudo et al., 2003) and from magnetic resonance imaging (Koziak, 
Winter, Lee, Thompson, & St. Lawrence, 2008). Another potential limitation was the 
possibility of variations in CBF between measurements from the different modalities. To 
minimize this, paCO2 was monitored frequently to ensure it remained stable during each 
capnic level. 
3.5 Conclusion 
In summary, contributions from the superficial layers (scalp and skull) were eliminated 
by exposing the cerebral cortex of juvenile pigs and acquiring DCS directly on the brain. 
In agreement with Carp et al., the flow model that demonstrated the best fit to the 
intensity autocorrelation functions was the hybrid flow model, as evident at early 
correlation times. However, BFI values from the BDM and the HDM were very similar and 
both were in agreement with the CBF changes measured by CTP, indicating that the 
diffusion-like flow of erythrocytes dominates. Furthermore, the BDM is the more practical 
model for characterizing DCS data due to its greater robustness. 
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Chapter 4  
4 Measurements of Cerebral Blood Flow in Adolescent 
Pigs by Diffuse Correlation Spectroscopy 
This chapter is adapted from the paper entitled “Assessment of a multi-layered diffuse 
correlation spectroscopy method for monitoring cerebral blood flow in adults” by 
Verdecchia K, Diop M, Morrison L, Lee T-Y, St. Lawrence K, published in Biomedical 
Optics Express, vol. 7(9) (2016). 
4.1 Introduction 
Patients requiring intensive care due to life-threatening neurological emergencies, such as 
ischemic stroke, traumatic brain injury and subarachnoid hemorrhage, are at high risk of 
secondary brain injury (De Oliveira Manoel et al., 2015; English et al., 2013; Kirkman, 
Citerio, & Smith, 2014). Although multiple factors contribute to poor outcome, a major 
focus is preventing delayed cerebral ischemia. For example, approximately one-third of 
patients with subarachnoid hemorrhage will develop secondary brain injury within two 
weeks of the initial event primarily due to cerebral vasospasm (Al-Tamimi, Orsi, Quinn, 
Homer-Vanniasinkam, & Ross, 2010). Consequently, a major focus of neurointensive 
care is maintaining adequate cerebral blood flow (CBF) through treatments such as 
administering nimodipine, inducing hypertension, and intervening with surgical or 
pharmacological angioplasty (Macdonald, 2014). A key component of patient 
management is the use of monitoring techniques to detect signs of impaired CBF, such as 
elevated flow velocities in cerebral arteries as measured by transcranial Doppler. 
However, this is not a direct measure of CBF and cerebral ischemia can occur without 
evidence of arterial narrowing (Dhar et al., 2012). Cerebral blood flow can be monitored 
directly by thermal diffusion and laser Doppler flowmetry (Kirkpatrick, Smielewski, 
Czosnyka, & Pickard, 1994; Vajkoczy et al., 2000), but these are invasive methods, 
which has hindered their wider applicability. To date, there remains no established 
bedside technique capable of monitoring CBF. 
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Near-infrared spectroscopy (NIRS) is a portable, non-invasive technology that can 
be used to monitor cerebral oxygenation at the bedside of critical-care patients (Obrig & 
Steinbrink, 2011; Zweifel et al., 2010). Cerebral blood flow can be measured directly 
using the optical dye indocyanine green as an intravascular contrast agent (Brown et al., 
2002; Steinkellner et al., 2010; Weigl et al., 2014). With the application of light 
propagation models to account for absorption in extracerebral tissues, this contrast-
enhanced approach can also provide quantitative CBF measurements (Elliott et al., 2014), 
but it is limited to single time point measurements. An alternative approach is diffuse 
correlation spectroscopy (DCS) that monitors changes in CBF by detecting speckle 
patterns caused by the motion of red blood cells (Baker et al., 2014; Boas, Campbell, & 
Yodh, 1995; Buckley, Parthasarathy, Grant, Yodh, & Franceschini, 2014). A normalized 
intensity autocorrelation curve is determined from the measured temporal speckle pattern, 
and a blood flow index is obtained by fitting the autocorrelation curve with an analytical 
solution to the correlation diffusion equation for a semi-infinite homogeneous medium 
(Cheung, Culver, Takahashi, Greenberg, & Yodh, 2001). A number of validation studies 
involving alternative methods of measuring blood flow have shown that DCS can track 
perfusion changes in the brain accurately (Buckley et al., 2014; Durduran & Yodh, 2014). 
Modeling DCS data in this manner is reasonable if contributions from extracerebral 
tissues are small such as for neonates and certain animal models (Buckley et al., 2014; 
Diop, Kishimoto, Toronov, Lee, & Lawrence, 2015; Lin et al., 2013). However in the 
adult head, reflected light measured on the scalp must travel through more substantial 
extracerebral layers (i.e. scalp and skull), leading to partial volume errors and 
underestimations of CBF. 
A number of approaches have been proposed to account for tissue heterogeneity 
when applying DCS to monitor CBF in adults, starting with the use of a correction factor 
based on partial volumes estimates (Durduran et al., 2004). Another approach is to weight 
the model fit to shorter correlation times since these represent longer photon pathlengths 
(i.e. photons that have a greater chance of having propagated deeper into tissue) (Baker et 
al., 2015; Selb et al., 2014). However, these methods can only enhance the sensitivity to 
CBF but do not completely separate the effects of light propagation and blood flow in the 
various tissues. A more direct approach is to adapt a multi-layered solution to the 
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diffusion approximation that accounts for the contribution of the extracerebral layers. 
Using Monte Carlo simulations and layered tissue phantom, this approach has been 
shown to improve the sensitivity to CBF (Gagnon, Desjardins, Jehanne-Lacasse, Bherer, 
& Lesage, 2008), and it has been used to analyze DCS data acquired from participants 
performing a functional task (Li et al., 2005). These studies highlight the importance of 
using a theoretical model that accounts for extracerebral tissue layers to improve 
sensitivity to cerebral tissue when analyzing DCS data acquired on the adult head.  
The current study investigates the application of a multi-layered (ML) DCS model 
to data acquired at multiple source-detector distances with the aim of separating brain and 
scalp blood flow. Two sets of experiments were conducted to assess the improved depth 
sensitivity of the ML modeling approach. First, a two-layered tissue-mimicking phantom 
was constructed in which the pseudo-flow property of each layer could be independently 
altered. Data were acquired at two source-detector distances while the diffusion 
coefficient in the deeper layer was gradually increased. Second, the approach was applied 
to measuring CBF in a juvenile swine model, which was chosen because the thickness of 
the extracerebral layers is similar to that of the adult human head. Cerebral blood flow 
was reduced by altering blood CO2 tension from normocapnia to hypocapnia. For 
validation, CBF was independently measured by computed tomography perfusion (CTP) 
(Elliott et al., 2014; Lee, 2002). 
4.2 Theory 
With DCS, the measured temporal intensity fluctuations are used to compute the 
normalized intensity autocorrelation function, g2(ρ,τ) (Cheung et al., 2001): 
g>ρ, τ ≡ 〈V,V,;W〉〈V,〉F     (4.1) 
where, <I(ρ,t)> is the light intensity measured by a detector located at a distance ρ from 
the source at time t, and τ is the correlation time. Equation 1 is related to the electric field 
autocorrelation function, G1(ρ,z,τ) ≡ <E(ρ,z,τ) • E*(ρ,z,t+τ)>, by the Siegert relation 
(Lemieux & Durian, 1999): 
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g>ρ, τ = 1 + β |[\,,W|F〈V,〉F     (4.2) 
where, β is the coherence factor of the detection system. It has been shown for a high 
scattering, low-absorbing medium, such as tissue, that G1(ρ,z,τ) can be modeled by the 
correlation diffusion equation at a depth z in the medium (Boas et al., 1995; Skipetrov & 
Maynard, 1996). By modeling the medium as a series of parallel slabs over a semi-
infinite medium, the diffusion equation is given by (Boas et al., 1995; Skipetrov & 
Maynard, 1996): 
P∇> − μ>τGρ, z, τ = −?Sδ −    (4.3) 
where, Pi = v/(3µai + 3µ́si) is the photon diffusion coefficient in layer i, v is the speed of 
light, µai is the absorption coefficient and µ́si is the reduced scattering coefficient. S is the 
light source defined at an effective depth z0 (= 1/µś1) by the delta function δ − . 
Finally, µPi accounts for the loss of correlation due to dynamical processes (i.e. the 
motion of scatterers) and is given by: 
μ>τ = 3`p 8μ
 + 2μ k>αDτ<    (4.4) 
where, k0 = 2πn/λ is the wavenumber of light (λ is wavelength and n is the refractive 
index, which is set to 1.4 for all tissues), α represents the fraction of scattering events 
related to motion, which in tissue represents the fractional blood volume, and Di is the 
diffusion coefficient of the ith layer. If blood flow is modeled as a pseudo-Brownian 
process (Cheung et al., 2001), which is valid for brain (Verdecchia, Diop, Morrison, Lee, 
& St. Lawrence, 2015), then the blood flow index, Fi, is given by αDi. 
Modeling tissue as a semi-infinite homogeneous medium, the analytical solution 
to Equation 4.3 is given as [16,18]: 
Gρ, z, τ = 39: p/0 b
cde8\5\<
5\ −
cde8\5\<
5F g   (4.5) 
where, r1 = [ρ2 + z02]½, r2 = [ρ2 + (z0 + 2zb)2]½, and zb is the extrapolated boundary defined 
by 2P1(1 + Reff)(1 – Reff)-1 (Kienle & Glanzmann, 1999). The effective reflection 
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coefficient, Reff, is given by 0.493 for the refraction indices of tissue and air (Haskell et 
al., 1994). In the general case consisting of parallel slabs on a semi-infinite medium, the 
field autocorrelation function at the surface (i = 0), Gs, z, τ, can be determined by 
solving Equation 4.3 in the Fourier domain (Li et al., 2005): 
Gs, z, τ = *Gρ, z, τed>ρ         (4.6) 
Similar to Li et al., the appropriate boundary conditions were applied to Gρ, z, τ, which 
is obtained by numerically computing the inverse Fourier transform of Gs, z, τ at the 
surface (Gagnon et al., 2008; Li et al., 2005): 
Gρ, z, τ = >0* Gs, z = 0, τsJsρdsP    (4.7) 
where s is the radial spatial frequency, J0 is the Bessel function of zeroth order computed 
by the MATLAB function besselj and the solution of Gs, z, τ. The Hankel transform in 
Equation 4.7 was computed numerically by rearranging the solution for a three-layered 
model to the form of the Gauss-Laguerre quadrature in MATLAB: 
Gs, z, τ = c5
5c
5    (4.8) 
numerator = 	S0, z − zD
× z μ\P cosh =μ4L − zD@ μFP> cosh8μFL><
+ μ3P3 sinh8μ>L>< 	
+ μFP> sinh =μ\L − zD@ μP3 cosh8μFL>< + μFP> sinh8μFL>< 
109 
 
denominator = 	μFP> cosh8μFL>< μ\ cosh8μ\L< 8P + μP3z<
+ sinh8μ\L< 8μP3 + μ\> Pz<
+ sinh8μFL>< bμ\ cosh =μL8μPP3 +	μF> P>>z<@
+ sinh8μ\L< 8μF> P>> + μ\> μ3PP3z<g 
where, µP̃i2(s,τ) = µPi2(τ) + s2 for the ith layer, and L1 and L2 are the thicknesses of the first 
and second tissue layers (i.e. scalp and skull, respectively); the third layer is brain, which 
is assumed to be infinitely thick. 
4.3 Methods 
4.3.1 Instrumentation 
4.3.1.1 Hybrid Optical System 
The light source of the DCS instrument was a continuous-wave laser (DL785-100-S, 
CrystalLaser, Nevada) emitting at 785 nm with a maximum output power of 100 mW and 
a coherence length >5 m. The emitted light was attenuated by electronically controlled 
variable neutral density filters and coupled to a multimode emission fiber (N.A. = 0.22, 
core = 400 µm; Fiberoptics Technology, Pomfret, CT). Twelve single-mode fibers (SMF-
28e +, N.A. = 0.14, length = 4 m, core = 8.2 µm, single-mode cutoff wavelength at 1260 
nm) were split into separate fiber bundles located at source-detector distances (SDDs) of 
20 and 27 mm. Due to the considerable drop in light intensity with distance, one fiber 
was placed at 20 mm and the remaining 11 were placed at 27 mm. Each fiber was 
coupled to the input of a single photon counting module (SPCM-AQ4C, Excelitas 
Canada Inc). The output of each SPCM was sent to a 16-channel photon correlator board 
(DPC-230, Beker & Hickl) that computed the normalized intensity autocorrelation 
functions, g2(ρ,τ). 
Tissue optical properties (i.e. µa and µś) were measured by a TR NIRS system 
described in detail elsewhere, (Diop et al., 2010; Verdecchia et al., 2015). Briefly, the 
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instrument consisted of a picoseconds pulsed diode laser (LDH-P-C 764, PicoQuant, 
Germany) emitting at 764 nm with an average output power and pulse repetition rate of 
1.4 mW and 80 MHz, respectively. The light was guided by the same type of optical fiber 
as the DCS emission probe; the two probes were bundled together to emit light at the 
same location. The pulsed light was detected by 121 optical fibers (core = 200 µm, 
cladding = 220 µm, N.A. = 0.22, length = 0.5 m), which were bundled together with the 
11 DCS single-mode detection fibers located at the SDD of 27 mm. Collected photons 
were guided to a fast hybrid photomultiplier detector (PMA Hybrid, PicoQuant, 
Germany) whose output was sent to a time-correlated single-photon counting (TCSPC) 
module (HydraHarp 400, PicoQuant, Germany). At the end of the study, the instrument 
response function (IRF) was measured to account for instrument-related temporal 
dispersion (Ntziachristos & Chance, 2001). 
4.3.1.2 Computed Tomography Perfusion 
All CT imaging was performed with a Revolution CT scanner (General Electric 
Company, Waukesha, WI). Perfusion images were acquired by performing a dynamic 
contrast-enhanced protocol, which involved serial acquisition of image volumes, one 
acquired every second, for 40 seconds (200 mA, 80 kVp, 2.5-mm slice thickness, and a 
FOV of 140 x 140 x 40 mm). Each volume consisted of 32 coronal slices, which 
encompassed the entire head. The beginning of the dynamic scanning was immediately 
followed by a bolus injection of 1.0 mL/kg of iodine-based contrast agent (iopamidol 
[370-Isovue®], Bracco S.p.A., Milan, Italy) at a rate of 3 mL/s into the cephalic vein. 
4.3.2 Experimental Procedure 
4.3.2.1 Two-Layered Diffusion Phantom Experiment 
A two-layered phantom was designed using computer-aided 3D drawing software 
(Rhinoceros 5; Robert McNeel & Associates, North America). It was constructed from 
dark polyvinyl chloride (12 mm thick) and had internal dimensions of 180 x 140 x 110 
mm. Two layers were created by inserted a polyester Mylar sheet (polyethylene 
terephthalate; McMaster-Carr) with a thickness of 25.4 µm. The Mylar sheet was framed 
by a clear polycarbonate that could be positioned at a depth of either 5 or 10 mm from the 
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top of the box. Three holes were drilled into the top of the box to hold the probes in 
place: one emission fiber and two detection fibers at SDDs of 20 and 30 mm. To mimic 
the light scattering properties of tissue, both layers were filled with 0.8% Intralipid 
(Fresenius Kabi, Germany). The viscosity in the bottom layer was increased by adding 
methyl cellulose (4000 cP; Sigma-Aldrich, St. Louis, MO) (Cheung et al., 2001).  
To replicate the homogeneous condition, DCS data were first acquired at a SDD 
of 30 mm and multiple cellulose concentrations (0, 0.05, 0.1, 0.15, and 0.2%), but 
without the Mylar membrane. In addition to acquiring DCS data, µa and µ́s were 
measured by TR NIRS at each cellulose concentration. Next, the membrane was inserted 
to create a top layer with a thickness of 5 or 10 mm. DCS data were acquired at 20 and 30 
mm while increasing the cellulose concentration in the bottom layer from 0 to 0.2%, but 
maintaining the top-layer concentration at 0%. Data acquired with the homogeneous 
phantom were analyzed by the analytical solution (Equation 4.5) for the homogeneous 
model (DCSHM). Data acquired with the two-layered phantom were analyzed with 
DCSHM (SDD = 30 mm) and ML DCS method using data from both separations. 
4.3.2.2 Animal Experiments 
Experiments were conducted under the guidelines of the Canadian Council of Animal 
Care (CCAC) and approved by the Animal Use Sub-Committee at Western University. 
The animals were obtained from a local supplier on the day of the experiment. Following 
anesthetic induction with 5% isoflurane, the animals were tracheotomized and 
mechanically ventilated on a mixture of oxygen and medical air. A catheter was inserted 
into a femoral artery for blood gas analysis. After surgery, isoflurane was reduced to 3-
4% and the animal was transported to the CT suite where the experiments were 
conducted. 
Before data collection, CT scout images were acquired to determine the best 
location for the probe holder on the head (i.e. the position corresponding to the largest 
brain diameter). During the experiment, arterial oxygen saturation, heart rate (HR), 
respiratory rate, mean arterial pressure (MAP), and rectal temperature were continuously 
monitored. Arterial blood samples were obtained to measure arterial pH, the arterial 
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partial pressure of carbon dioxide (paCO2), the arterial partial pressure of oxygen (paO2), 
the concentration of blood glucose (BG), and the total blood hemoglobin concentration 
(ctHb). Samples were acquired before and after each set of measurements to assess 
physiological stability during data acquisition. The order for the three modalities was 
CTP, TR NIRS, and DCS at normocapnia (paCO2 between 38 and 42 mmHg) and 
reversed at hypocapnia (paCO2 between 20 and 25 mmHg) to avoid removing the DCS 
probes from the head between measurements. Each capnic level was maintained by 
adjusting the ventilation volume and rate. To investigate if the multi-distance DCS 
measurements were affected by scalp blood flow, the acquisition protocol was repeated 
after creating incisions in the scalp around three lateral sides of the probe holder to 
reduce scalp blood flow (Elliott et al., 2014). 
4.3.3 Data Analysis 
4.3.3.1 Computed Tomography Perfusion 
Maps of CBF were calculated using the CT perfusion software package PERFUSION 5 
(GE Healthcare Worldwide), which was developed and validated in-house (Cenic, 
Nabavi, Craen, Gelb, & Lee, 1999). Region-of-interest (ROI) analysis was performed 
using in-house developed software that performed pixel thresholding to remove signal 
contributions from large vessels that can lead to CBF overestimations (Murphy et al., 
2006). For each slice, three ROI’s (~5 cm2) were manually drawn on the scalp, skull, and 
cerebral cortex, as seen in Figure 4-1. The location of the scalp ROI was located laterally 
to the actual positions of the DCS probes. This was done to avoid motion artifacts near 
tissue interfaces such as bone and scalp caused by breathing. The brain ROI was drawn 
on the cerebral cortex since the NIRS signal is more sensitive to superficial brain tissue 
than deeper white matter. Absolute blood flow values for each of the three tissues (scalp, 
skull and brain) were obtained by averaging ROIs across ten to twelve sequential slices. 
Finally, the thicknesses of the scalp and the skull (i.e. L1 and L2, respectively) were 
measured by image-viewing software (AW VolumeShare 4, GE Healthcare). 
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Figure 4-1: Single slice of the intact head of a pig: anatomical and perfusion map 
CT images 
Coronal CT image of a pig’s head (A) and the corresponding blood flow map (B). The scalp (1), skull (2) and 
brain (3) ROIs are shown in white. Bar codes are given to illustrate relative x-ray attenuation (A) and blood 
flow in mL/min/100g (B). 
4.3.3.2 Diffuse Correlation Spectroscopy 
All intensity autocorrelation functions were acquired over an integration time between 30 
and 90 s depending on the achieved count rate. Measured g2(ρ,τ) functions were 
converted to the field autocorrelation function by Equation 4.2. Data were analyzed using 
both solutions to the diffusion approximation: the semi-infinite homogeneous model 
(Equation 4.5) and the ML model (Equations 4.6 and 4.7). Estimates of the diffusion 
coefficients were determined using a non-linear least squares fitting routine (MATLAB© 
function fminsearchbnd with Di values constrained to be positive) to fit an analytical 
model to g2(ρ,τ). For the homogeneous model, data from one SDD were analyzed to 
generate a diffusion coefficient for the tissue-mimicking phantom or a blood flow index 
denoted FHM for the in vivo data. These values were derived using the values of µa and µ́s 
measured by TR NIRS, which were also determined by the solution to the diffusion 
approximation for a semi-infinite homogeneous medium (Diop, Verdecchia, Lee, & St 
Lawrence, 2011). The fitting was performed for correlation times from 1 µs up to times 
corresponding to g1(ρ,τ) > 0.5, since focusing the fit of the autocorrelation function to 
short correlation times increases the sensitivity to deeper propagating photons (Selb et al., 
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2014). For the animal experiments the g2(ρ,τ) functions acquired at 20 and 27 mm were 
analyzed separately and denoted FHM,1 and FHM,2, respectively. 
For the ML DCS model, the g2(ρ,τ) functions acquired at the two SDDs were 
analyzed simultaneously. The µa and µ ́s values for all three layers were set to the values 
obtained from TR NIRS using the homogeneous model, and L1 and L2 values were 
obtained from the CT images.  For each animal, the coherence factor (β) was estimated 
prior to the fitting by averaging the first five points of each autocorrelation function. To 
focus on deeper propagating photons, the fitting was performed between correlation times 
defined by g2(ρ,τ) < 0.8 to 0.1 s for the shorter SDD (20 mm), and 1 µs to g2(ρ,τ) > 0.5 
for the longer SDD (27 mm). For the flow phantom, the two fitting parameters were the 
diffusion coefficients in the top and bottom layers (DT and DB, respectively). Similarly, 
the fitting parameters for the analysis of the in vivo data were the blood flow indices in 
scalp and brain (denoted FS and FB, respectively), assuming negligible flow in the middle 
(skull) layer. 
4.3.3.3 Statistical Analysis 
Uncertainties are given as the standard error of the mean unless otherwise stated. All 
statistics were computed with the IBM SPSS Statistics 20 software package. For the 
phantom experiments, linear regression analysis was conducted to identify a significant 
relationship between increasing viscosity in the bottom layer and the measured diffusion 
coefficients (DT and DB). 
For the animal experiments, possible changes in the measured physiological 
parameters and optical properties due to altering paCO2 or the scalp incisions were tested 
by a repeated measures analysis of variance (ANOVA). The same test was conducted on 
all measured flow parameters, which include the blood flow estimates for scalp, skull and 
brain measured by CTP, and for the blood flow indices measured by DCS techniques: FS 
and FB from the ML DCS analysis, and FHM,1 and FHM,2 from the homogeneous model. 
Relative blood flow changes measured by CTP and ML DCS when paCO2 was altered 
from normocapnia to hypocapina were compared by a paired t-test. Finally, Bland-
Altman analysis was conducted to compare the reductions in CBF and FB obtained by 
115 
 
CTP and ML DCS, respectively. This included a one-sample t-test to identify differences 
between the two modalities and linear regression to determine proportionality bias. 
4.4 Results 
4.4.1 Phantom Experiments 
Figure 4-2 illustrates the relative change (i.e. from 0% cellulose) in the estimated 
diffusion coefficient from the homogeneous model (A) and the ML DCS model (B) as the 
viscosity in the bottom layer of the phantom was increased by adding cellulose. In the 
latter case, the diffusion coefficient from the bottom layer (DB) is shown. For 
comparison, each graph also includes the measured change in the diffusion coefficient for 
the homogeneous phantom. 
 
Figure 4-2: Relative change in the measured diffusion coefficient from the deepest 
layer of a multi-layered phantom: analyzed by homogeneous and heterogeneous 
DCS flow models 
Relative change in the measured diffusion coefficient as the viscosity of the tissue-mimicking phantom was 
increased. The label ‘expected’ refers to the homogeneous case (blue bars), and the labels ‘5 mm’ and ‘10 
mm’ refer to thickness of the top layer for the two-layered case (red and green bars, respectively). For the 
two-layered experiments, cellulose was only added to the bottom layer. (A) Diffusion coefficient determined 
by analyzing the two-layered data with the homogeneous model (SDD = 30 mm). (B) Diffusion coefficient for 
the bottom layer of a two-layered model applied to the same data used in (A). This analysis used data 
acquired at SDD of 20 and 30 mm. 
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The results in Figure 4-2A were obtained using the HM-DCS model to 
characterize the g2(ρ,τ) curves acquired at a SDD of 30 mm, and as expected the 
magnitude of the error was larger as the top layer thickness increased. The results in 
Figure 4-2B were obtained using the ML DCS model to characterize g2(ρ,τ) acquired at 
SDDs of 20 and 30 mm. Linear regression analysis indicated that increasing the viscosity 
in the bottom layer significantly reduced DB, but had no effect on DT for either a 5 or 10 
mm thick top layer. The optical properties measured by TR NIRS in the homogeneous 
phantom were µa = 0.033 ± 0.003 cm-1 and µ ́s = 8.5 ± 0.2 cm-1. 
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4.4.2 Animal Experiments 
4.4.2.1 Physiological Experiments 
Experiments were conducted on seven pigs (all female) with an average weight of 15.5 ± 
0.4 kg and average scalp and skull thicknesses of 3.5 ± 0.2 mm and 6.4 ± 0.4 mm, 
respectively. For all physiological parameters, significant differences were observed pre- 
and post-scalp incision, except for pH, paCO2 and paO2.  
As expected, significant differences between normocapnia and hypocapnia were 
observed for pH and paCO2 [p<0.001, partial-η2 > 0.98, Power = 1]; however, a 
significant change in paO2 and MAP were also observed [p<0.05, partial-η2 > 0.69, 
Power > 0.85] (see Table 4-1). Significant changes were not observed for any of the other 
measured physiological parameters. Their mean values were 38.4 ± 0.1 °C (temperature), 
120 ± 2 beats per minute (HR), 5.3 ± 0.2 mmol/L (BG) and 9.2 ± 0.1 g/dL (ctHb). Lastly, 
no differences were observed in µa (0.168 ± 0.008 cm-1) and µ́s (9.0 ± 0.8 cm-1) between 
capnic conditions. 
Table 4-1: Physiological parameters during normocapnia and hypocapnia 
Condition *pH *paCO2 (mmHg) *paO2 (mmHg) *MAP (mmHg) 
Normocapnia 7.473 ± 0.006 39.5 ± 0.4 173 ± 10 41 ± 1 
Hypocapnia 7.658 ± 0.006 22.2 ± 0.4 210 ± 10 38 ± 1 
Average values at normocapnia and hypocapnia for the arterial partial pressure of carbon dioxide (paCO2,) 
and oxygen (paO2). * p<0.05 between conditions. Data are presented as average ± SEM. 
4.4.2.2 Absolute Blood Flow 
Five blood flow index sets (FS and FB) measured by ML DCS out of a total of 28 were 
removed due to either a large residue (i.e. > 0.01) in the optimization procedure (two 
cases) or an FB value that approached zero (i.e. < 10-9) (one case). Lastly, both sets of 
g2(ρ,τ) curves (i.e. during normocapnia and hypocapnia) from one experiment were 
removed due to poor coupling between the optical probes and skin. 
Normalized intensity autocorrelation curves from one experiment are plotted in 
Figure 4-3. This set was chosen as the FB values at normo- and hypo-capnia were similar 
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to the average values across all animals. The shift to longer correlations times from 
normocapnia to hypocapnia evident in Figure 4-3 represents a -38.7 % flow change 
measured by ML DCS. 
 
Figure 4-3: Measured DCS decay curves acquired on the intact head of a pig during 
normocapnia and hypocapnia 
Normalized intensity autocorrelation functions acquired during normocapnia (red curve) and hypocapnia 
(blue curve) at SDD of 20 mm (A) and 27 mm (B) with count rates of ~465 and ~55 kHz, respectively. The fit 
of the ML DCS model is illustrated by the black curve. 
No significant changes in any of the blood flow indices (i.e. FS and FB values 
from the ML DCS analysis and FHM from the HM-DCS analysis) were found by 
comparing values pre and post scalp incisions. This unexpected finding was likely due to 
increased variability in the DCS signal due to probe pressure effects since it was 
necessary to remove the fibers to perform the incisions (Mesquita et al., 2013). 
Consequently, capnic data before and after scalp incision were grouped together in all 
subsequent analysis. Note, SBF measured by CTP did not change with scalp incisions 
since the scalp ROI (Figure 4-1) was lateral to probe location to avoid breathing-related 
motion artifacts.  
Figure 4-4 plots the blood flow estimates obtained by CTP and DCS for the two 
paCO2 conditions. Significant differences between normocapnia and hypocapnia were 
found for CBF measured by CTP [p<0.001, partial-η2 = 0.984, Power = 1] and FB 
measured by ML DCS [p<0.05, partial-η2 = 0.816, Power = 0.685]. Significant 
differences were also found for FHM at a SDD of 20 mm [p<0.05, partial-η2 > 0.876, 
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Power > 0.852] and a SDD of 27 mm [p<0.05, partial-η2 > 0.826, Power > 0.710]. In 
contrast, no significant differences between capnic conditions were found for SBF 
measured by CTP, and FS measured by ML DCS. Finally, skull flow measured by CTP 
(8.9 ± 0.7 mL/min/100g) and the coherence factors β (0.158 ± 0.001 and 0.168 ± 0.002, 
for SDD of 20 and 27 mm, respectively) did not change significantly with paCO2 (data 
not shown). 
 
Figure 4-4: Absolute blood flow in the scalp and brain measured by CTP and DCS 
during normocapnia and hypocapnia 
Scalp blood flow (SBF) and cerebral blood flow (CBF) measured by CT, and the corresponding blood flow 
indices measured by DCS during normocapnia (red bars) and hypocapnia (blue bars). All values were 
averaged over their pre- and post- scalp incision measurements. FS and FB were obtained from the ML 
model analysis of DCS data acquired at SDDs of 20 and 27 mm. FHM was obtained by analyzing data from 
each SDD separately with the HM model (FHM,1 refers to 20 mm and FHM,2 refers to 27 mm). Significant 
differences observed between capnic conditions are represented by *. 
Table 4-2: Mean absolute flow values in the scalp and brain measured by CTP and 
DCS during normocapnia and hypocapnia 
Capnic 
Condition 
*CBF 
(mL/min/100g) 
*FB 
(10-9 cm2/s) 
SBF 
(mL/min/100g) 
FS 
(10-9 cm2/s) 
*FHM,1 
(10-9 cm2/s) 
*FHM,2 
(10-9 cm2/s) 
Normocapnia 52.4 ± 1.7 52.3 ± 6.9 18.1 ± 1.5 7.3 ± 2.1 7.1 ± 1.3 7.7 ± 1.1 
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Hypocapnia 33.2 ± 1.7 36.3 ± 4.2 19.0 ± 1.2 5.0 ± 1.2 6.0 ± 1.3 6.1 ± 1.0 
Average flow values (CBF and SBF, FB and FS) measured by CTP and ML DCS, respectively, for 
normocapnic and hypocapnic conditions. Significant differences between capnic conditions are indicated by 
*. 
A significant Pearson correlation (R = 0.538) was observed between CBF and FB. 
Likewise, significant correlations were observed between FS and both FHM,1 (R = 0.972) 
and FHM,2 (R = 0.881). 
4.4.2.3 Relative Blood Flow 
The relative change in CBF and DCS indices when reducing paCO2 from normocapnia to 
hypocapnia are presented in Figure 4-5. 
 
Figure 4-5: Comparison between the percent difference of CBF measured by CTP 
and different DCS flow models acquired on the skin of the intact head of pigs 
(A) Box plot of relative flow change caused by reducing paCO2 from normocapnia to hypocapnia. Flow 
values of CBF, FB, FHM,1 and FHM,2 measured by CTP (N = 14), ML DCS (N = 11), DCSHM,1 (N = 14) and 
DCSHM,2 (N = 14), respectively. The center line, box edges, error bars, and the cross represent the median, 
1st and 3rd quartiles, CI95%, and outliers, respectively. Significant changes compared to CBF are 
represented by *. (B) Bland-Altman plot comparing reductions in CBF and FB measured by CTP and ML 
DCS (N = 11). The mean difference between the two modalities, the standard error of the mean, and the 
CI95% are indicated by the solid line, the dotted line and the dashed line, respectively. Flow change 
measured while the scalp tissue was intact or incised is represented by circle and diamond symbols, 
respectively. 
Mean CBF reduction measured by CTP (−36.4 ± 3.3 %) was not significantly 
different from the corresponding FB change (−33.5 ± 4.5 %). In contrast, the FHM,1 change 
(-13.2 ± 7.5 %) was significantly different from both the CTP and ML DCS results. 
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Similarly, the change in FHM,2 (-19.1 ± 6.0 %) was significantly different from CTP 
results and a trend was observed when compared to FB (p = 0.054). A Bland-Altman 
analysis comparing relative CBF changes measured by CTP and ML DCS is shown in 
Figure 4-5B. The mean difference between the two modalities was -1.2 ± 4.6 % (CI95%: -
31.1 and 28.6). Linear regression analysis of the Bland-Altman plot indicted a significant 
proportional bias (p<0.001, R = 0.837). 
4.4.2.4 Real-Time Flow Monitoring 
To demonstrate the ability of ML DCS to resolve dynamic differences in scalp and brain 
blood flow, a series of g2(ρ,τ) curves acquired during the transition from normocapnia to 
hypocapnia from one experiment were analyzed (Figure 4-6). In this example, the flow 
change calculated by the difference between means of the first and last minutes was -42.9 
% in the brain and 5.2 % in the scalp. The coefficients of variation for the baseline scalp 
and brain time series were 9.8 % and 8.4 %, respectively. 
 
Figure 4-6: Real-time change of scalp and brain BFIs measured during the 
transition from normocapnia to hypocapnia 
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Blood flow dynamics during the transition from normocapnia to hypocapnia from one experiment. Each 
g2(ρ,τ) curve was acquired for 2 seconds and analyzed separately by the ML DCS model to obtain time 
series of FB and FS. Data were acquired at a count rate of 554.3 ± 0.4 kHz and 101.5 ± 0.2 kHz at SDDs of 
20 mm and 27 mm, respectively. The thickness of the scalp and the skull were 3.7 ± 0.4 mm and 6.0 ± 0.4 
mm, respectively. 
4.5 Discussion 
The aim of this work was to test the ability of a depth-sensitive DCS approach to retrieve 
the blood flow index from the brain despite the presence of a substantial superficial tissue 
layer. The approach was based on obtaining two autocorrelation functions with varying 
depth sensitivities by placing detectors at distances from the source of 20 and 27 mm. 
The multi-distance data were then analyzed with a three-layered solution to the 
correlation diffusion equation to account for light propagation through scalp, skull and 
brain, and the different blood flows in scalp and brain (Li et al., 2005). Rather than fitting 
a complete autocorrelation curve, different ranges of correlation times were used to fit the 
curves obtained at the two source-detector distances in order to alter the weighting to 
shorter or longer photon pathlengths (Farzam & Durduran, 2015; Selb et al., 2014). More 
specifically, the range for the longer SDD (27 mm) was restricted to early correlation 
times, while longer correlation times were selected for the shorter SDD (20 mm). 
The feasibility of the ML DCS approach was first verified using a two-layer 
tissue-mimicking phantom in which the diffusion property of the bottom layer was 
altered by adding four different cellulose concentrations (Cheung et al., 2001). The 
change in the measured diffusion coefficient of the bottom layer, which varied from 20% 
to 80% by increasing the cellulose concentration, was in good agreement with the change 
observed in the homogeneous phantom over the same concentration range (Figure 4-2). 
In contrast, as expected, the diffusion coefficient of the 10-mm thick top layer did not 
change when cellulose was added to the bottom compartment (data not shown). In 
agreement with Gagnon et al. (Gagnon et al., 2008), these results highlight the ability of a 
multi-layered model to resolve differences in flow rates in different layers with minimal 
crosstalk between the measured diffusion coefficients. 
The second aim of the study was to apply the same ML DCS approach to an 
animal model in which CBF was independently measured by CT perfusion. Juvenile pigs 
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were selected as the total thickness of their extracerebral tissues was expected to be 
similar to that of adult humans. The mean values of scalp and skull thicknesses were 3.5 
± 0.2 and 6.4 ± 0.4 mm, respectively, which are within the expected range for humans, 
although larger values can be found depending on the location on the head (Strangman, 
Zhang, & Li, 2014). Global CBF was reduced by lowering paCO2 from normocapnia to 
hypocapnia. Overall, good agreement was found between the average CBF reductions 
measured by CTP (36.4 ± 3.3 %) and ML DCS (33.5 ± 4.5 %). The corresponding 
estimates of cerebrovascular reactivity (CVR), defined as the change in CBF per unit 
change in paCO2, were -1.9 ± 0.2 % per mmHg and -1.7 ± 0.2 % per mmHg for CTP and 
ML DCS, respectively. These estimates are in good agreement with our previous studies 
involving this animal model: -2.3 % per mmHg from CTP and -2.3 % per mmHg from 
DCS probes placed directly on the exposed cerebral cortex (Elliott et al., 2014; 
Verdecchia et al., 2015). In addition, good agreement was also found between the 
absolute blood flow index determined from ML DCS (Table 4-2: Mean absolute flow 
values in the scalp and brain measured by CTP and DCS during normocapnia and 
hypocapnia) and our previous values derived from autocorrelation functions measured 
directly on the brain, (~48x10-9 cm2/s at normocapnia and ~28x10-9 cm2/s at hypocapnia) 
(Verdecchia et al., 2015). This agreement suggests that FB could be used as a marker to 
track longitudinal changes in CBF, similar to previous DCS studies involving infants 
(Roche-Labarbe et al., 2012). However, this would require careful assessment of the 
reproducibility of FB considering the added complexity of the analysis. Intriguingly, the 
group-wise variability in FB (~40%) was in good agreement with previous studies in 
which the blood flow index was derived from the semi-infinite homogeneous model 
(Diop et al., 2011; Verdecchia et al., 2015). This is despite the addition of a scalp blood 
flow index (i.e. Fs) in the fitting routine.  
Although the results of this study demonstrate that a multi-layered modeling 
approach can account for the effects of extracerebral tissue, the accuracy of FB will be 
affected by errors in the additional model input parameters (i.e. the thicknesses of scalp 
and skull, and tissue optical properties). To assess the sensitivity to uncertainties in the 
thickness measurements, the g2(ρ,τ) curves from the tissue-mimicking phantom with a 
10-mm top layer were re-analyzed with the top layer thickness varied by ± 20%. The 
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resulting error in the diffusion coefficient for the bottom layer was less than 10%, similar 
to that reported by Gagnon et al. (2008). In clinical practice, the thicknesses of the scalp 
and skull could be obtained from medical images or possibly measured directly using 
ultrasound. Alternately, the total scalp/skull thickness could be included as an additional 
fitting parameter, similar to an approach proposed for measuring cerebral oxygenation by 
multi-distance frequency-domain NIRS (Hallacoglu, Sassaroli, & Fantini, 2013). This 
would likely require more SD distances than used in the current study and careful 
attention to the shortest SDD in order to avoid violating the Siegert relationship (Binzoni, 
Sanguinetti, Van de Ville, Zbinden, & Martelli, 2016). Regarding the optical properties, 
all three tissue layers were set to the single µa and µ ́s values measured by TR NIRS since 
the primary focus was assessing the ability of DCS to measure changes in CBF, which is 
fairly insensitive to uncertainties in absolute µa and µ ́s (Diop et al., 2011; Irwin et al., 
2011). Separate values of µa and µ ́s for each tissue layer could be obtained using a multi-
layer solution to analyze the TR NIRS data (Diop & St Lawrence, 2013; Liemert & 
Kienle, 2013). 
An alternative and simpler approach to account for partial volume errors is to 
multiply the change in the blood flow index obtained from the homogeneous model by a 
correction factor based on the partial pathlength through brain (Durduran et al., 2004; 
Gagnon et al., 2008; Selb et al., 2014). Durduran et al. (2004a) initially used a value of 5 
based on modeling the head as a two-layered medium. More recently, Selb et al. 
proposed a factor of 3 by restricting the fitting to early correlation times. In the current 
study, correction factors of 2.4 and 1.8 were found for SDDs of 20 and 27 mm, 
respectively, by comparing the mean change in FHM to the CBF change measured by 
CTP. Similarly, a factor of 1.5 was determined from the tissue phantom experiments with 
a 10-mm thick top layer and a SDD of 30 mm. The smaller values at larger separations 
(27 and 30 mm) would be expected given the improvement in depth sensitivity as the 
SDD is increased. Although applying a correction factor is simpler than using a multi-
layered model, high variability across experiments was found. In this study, the 
correction factor varied by ± 60% across animals. Furthermore, the similarity between 
mean FHM and FS values in Table 4-2: Mean absolute flow values in the scalp and brain 
measured by CTP and DCS during normocapnia and hypocapnia indicates that the DCS 
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signal is heavily weighted by extracerebral tissue. This sensitivity could lead to erroneous 
CBF estimates if scalp blood flow changed due to systemic effects or variations in 
surface probe pressure, highlighting the value of a multi-layered model to uncouple brain 
and scalp blood flow.  
An unexpected finding was the proportional bias revealed by regression analysis 
in the Bland-Altman plot (Figure 4-5B) despite similar flow changes measured by CTP 
and ML DCS (mean difference = -1.2 ± 4.6 %). This bias remained even after removing 
the outlier that had a mean CBF change greater than 50%. One explanation is the 
accuracy of the ML DCS approach could be affected by variations in the thickness of the 
extracerebral layer; however, no correlation with FB was found. Considering the range of 
CBF reductions was limited to between 20 to 40%, this bias should be viewed with 
caution. A wider range of flow changes, for instance by including hypercapnia 
experiments to increase CBF, would help to assess the validity of the observed bias. 
Another unexpected finding was an average perfusion signal in skull of 9 mL/min/100g 
measured by CTP. This would appear to contradict the assumption of the ML DCS 
method that skull has negligible blood flow. However, this value is likely artificial 
considering a similar ‘perfusion’ signal (10 mL/min/100g) was found in the probe holder 
(see Figure 4-1B). Likely this artifact is related to greater variability in flow estimates in 
areas of extremely low contrast enhancement. It should be noted that there was no change 
in skull blood flow between capnic levels. 
4.6 Conclusion 
In summary, this study demonstrates that DCS has the ability to separate scalp and brain 
blood flow, as demonstrated in Figure 4-6, despite the presence of a relatively thick 
extracerebral layer (of the order of 1 cm). The ML DCS technique could be further 
optimized by incorporating optical property measurements for the different tissue layers 
and by improving the SNR through the use of a software correlator to measure only 
relevant correlations times (Wang et al., 2016). Recent improvements for monitoring 
CBF were demonstrated in the adult head by a pressure modulation algorithm, without 
requiring a priori anatomical information (Baker et al., 2015). The approach taken by 
Baker et al. could be combined with the multi-layered model presented in this study to 
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isolate cerebral signals detected by DCS when estimating extracerebral tissue thickness 
by imaging methods is unavailable. Future work will implement a multi-layered 
DCS/TR-NIRS hybrid to demonstrate a means of quantifying the cerebral metabolic rate 
of oxygen in adults (Elliott et al., 2014; Verdecchia, Diop, Lee, & St. Lawrence, 2013). 
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Chapter 5  
5 Discussion/Conclusion 
The main objective of this thesis was to advance diffuse correlation spectroscopy (DCS) 
techniques with the long-term aim of assessing cerebral hemodynamics and metabolism 
in the intensive care unit (ICU). Typically, near-infrared spectroscopy (NIRS) measures 
tissue oxygen saturation but it also can measure CBF using an optical dye as an 
intravascular contrast agent (Brown et al., 2002). This approach has been subsequently 
adapted to time-resolved (TR) NIRS to improve its depth sensitivity and used to calibrate 
DCS in order to monitor absolute perfusion (Diop, Verdecchia, Lee, & St. Lawrence, 
2011). In chapter 2, this NIRS/DCS method was expanded to quantify the cerebral 
metabolic rate of oxygen (CMRO2). In chapter 3, the most appropriate flow model for 
DCS was investigated by acquired data directly on the brain. Chapter 4 outlined 
experiments aimed at assessing a multi-layered (ML) DCS method capable of measuring 
CBF through extracerebral tissues comparable in thickness to adults. The individual 
advancements in DCS techniques achieved in each chapter will be summarized in this 
chapter, and future work to further improve DCS will be discussed. Lastly, the main 
conclusions of the thesis will be listed. 
5.1 Summary 
The main objectives of this thesis focused towards advancing DCS techniques by: 
1) Demonstrating an all-optical device that includes DCS is capable of quantifying 
CMRO2. 
2) Furthering our understanding of the widely accepted diffusion model of flow 
applied to DCS. 
3) Implementing a multi-layered DCS model to separate flow in extracerebral and 
cerebral tissues. 
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Outlined in the following subsections is an overview of the progress to DCS methods 
made by the three objectives of this work. 
5.1.1 Quantification of CMRO2 by an all-optical modality 
Monitoring CBF at the bedside would improve patient outcome by detecting reductions 
in flow; however, additional monitoring of the metabolic rate would help evaluate tissue 
viability since CMRO2 is considered a better indicator of cerebral ischemia than CBF and 
oxygenation measurements alone (Powers, Grubb, Darriet, & Raichle, 1985; Tichauer et 
al., 2009; Tichauer, Brown, Hadway, Lee, & St. Lawrence, 2006). Diffuse correlation 
spectroscopy provides a means to monitor flow changes directly, but it is unable to assess 
the tissue metabolic demands. Combining DCS with NIRS has been used to measure 
changes in CMRO2 in the developing brain (Roche-Labarbe et al., 2010, 2012), but the 
inability of DCS to quantify CBF hinders the all-optical technique from establishing 
absolute metabolic thresholds. 
Recently, our group demonstrated that the DCS signal can be used to measure 
absolute perfusion through calibration with a TR NIRS bolus-tracking method (Diop et 
al., 2011). This technique was expanded in Chapter 2 to show that the combination of 
DCS with TR NIRS can also measure CMRO2. In this combination, DCS and contrast-
enhanced NIRS were used to measure CBF, and multi-wavelength TR NIRS was used to 
determine the cerebral venous blood oxygenation (SvO2), which was verified by directly 
measuring oxygenation in the sagittal sinus. Different cerebral metabolic rates were 
induced by altering the anesthetics in newborn pigs. This animal model was chosen since 
the scalp and skull are relatively thin and, hence, the optical measurements are principally 
from the brain. No significant differences were found between the two sets of SvO2 
measurements obtained by TR NIRS and sagittal sinus blood samples. In addition, 
Bland–Altman analysis showed a small difference in the corresponding CMRO2 values 
(0.027 ± 0.834 mL O2/100g/min) over a range from 0.3 to 4 mL O2/100g/min. This initial 
validation study demonstrates that quantitative CMRO2 values can be obtained by a 
DCS/NIRS hybrid system. 
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5.1.2 Measurements of Relative Blood Flow Changes Directly on 
Brain Parenchyma 
The normalized temporal intensity autocorrelation function generated by DCS is typically 
characterized by assuming that the movement of erythrocytes can be modeled as a 
Brownian diffusion-like process instead of by the expected random flow model (Cheung, 
Culver, Takahashi, Greenberg, & Yodh, 2001). Most applications of DCS accept the 
assumption that Brownian diffusion characterizes moving erythrocytes since this flow 
model approximates the computed autocorrelation function well (Durduran & Yodh, 
2014). Recently, a hybrid model, referred to as the hydrodynamic diffusion model, was 
proposed, which combines the random and Brownian flow models (Carp et al., 2011). 
Chapter 3 investigated the most appropriate flow model to describe 
autocorrelation functions used to monitor CBF. To avoid confounding effects of 
extracerebral tissues, these experiments were conducted with the probes placed directly 
on the brain. Relative flow changes were measured by DCS and were analyzed by three 
different flow models: random flow, Brownian diffusion, and the combined 
hydrodynamic diffusion model. Relative flow changes were verified by computed 
tomography perfusion (−39.7 ± 3.7%), of which, only the random flow model was 
significantly different (−63.2 ± 4.7%). No significant difference was found compared to 
the flow measurements derived using the Brownian and hydrodynamic diffusion models 
(-41.0 ± 4.3% and -44.2 ± 5.0 %, respectively). Although the latter provided better 
characterization of the autocorrelation functions, the Brownian diffusion model was more 
robust and, therefore, it is the most practical model for characterizing DCS data. 
5.1.3 Measurements of Relative Blood Flow Changes Through 
Thick Extracerebral Tissue 
Arguably the greatest challenge with DCS is the influence of superficial tissue on the 
detected signal. For simplicity, common DCS techniques assume tissue homogeneity; 
however in the adult head, extracerebral tissues, such as scalp and skull, lead to 
underestimations of CBF by DCS (Durduran et al., 2004; Gagnon, Selb, & Boas, 2008). 
Chapter 4 investigated a ML model that accounts for light propagation in multiple tissue 
layers, which was applied to DCS data acquired at multiple source-detector distances. 
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First, the ML DCS model was verified in a two-layer diffusion phantom by separating 
diffusion in the bottom and top layers. Next, global reductions in CBF (−33.5 ± 4.5 %) 
were measured by ML DCS in pigs with an extracerebral tissue thickness similar to 
adults (9.8 ± 0.4 mm). For validation, perfusion changes (−36.4 ± 3.3 %) were measured 
independently by computed tomography. Bland-Altman analysis determined a mean 
difference of -1.2 ± 4.6 % between the two flow modalities, which was bound by a 95% 
confidence interval of −31.1 to 28.6 %. This final study demonstrated that reductions in 
CBF can be measured accurately by ML DCS in adolescent pigs, which mimic the head 
of adults. 
5.2 Future Work 
5.2.1 Multi-Layered DCS/NIRS Hybrid System 
The main focus of the work completed in this thesis was towards advancing and 
validating DCS with the long-term goal of using this emerging optical method in 
combination with NIRS to monitoring CBF and CMRO2 in critical-care patients. In all 
three chapters, tissue optical properties were quantified by TR NIRS and input into the 
fitting routine of DCS. For DCS data analysis, the number of fitting parameters were 
reduced and, more importantly, the accuracy of the DCS fitting routine improved (Diop 
et al., 2011; Irwin et al., 2011). Notably, combining DCS with TR NIRS provides the 
ability to monitor both perfusion and CMRO2. 
Similar to DCS, TR NIRS is highly sensitive to superficial tissues, which result in 
underestimations of CBF (Gora et al., 2002). The excellent temporal resolution due to the 
measurement of the time-of-flight of photons by TR NIRS makes it possible to improve 
depth sensitivity by time-gating and moment analysis strategies (Diop & St. Lawrence, 
2013; Liebert, Wabnitz, & Elster, 2012). A previous colleague demonstrated that multi-
detector TR NIRS can accurately quantify CBF in a heterogeneous medium (Elliott et al., 
2014; Elliott, 2013). Naturally, similar to Diop et al. (Diop et al., 2011), the next step is to 
combine the dissertation work completed by Elliot (2013) with the ML DCS technique 
presented in Chapter 4 in order to calibrate changes in CBF in the adult head. This idea 
can be expanded by estimating optical properties for separate tissues using a multi-layer 
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solution to analyze the TR NIRS data (Liemert & Kienle, 2013). In turn, the cerebral 
oxygen saturation could be measured, and therefore, the method presented in Chapter 2 
could be used to measure CBF and CMRO2 in the adult head. 
5.2.2 Real-Time Data Acquisition 
The current NIRS/DCS hybrid device designed for the experiments conducted in this 
thesis did not have the capability to provide real-time monitoring. Simultaneous data 
acquisition of TR NIRS and DCS is not feasible due to the interplay of detected light, and 
alternating manually between optical components is required. A possible solution would 
be to automate transitions between NIRS/DCS components but would not allow 
simultaneous acquisitions. Installing band-pass filters would make concurrent NIRS and 
DCS measurements feasible by removing unnecessary wavelengths at the detection site 
of each component. A more challenging approach would be to design a detection system 
that utilizes the same components to generate both the autocorrelation functions and the 
TPSFs required for DCS and TR NIRS, respectively. 
 All data analysis in this thesis required post-analysis to compute the respective 
physiological parameters. Before transferring the NIRS/DCS system from the laboratory 
to the clinic, real-time digitization of measured data is needed. Specific for DCS, the 
current data throughput is relatively slow (~1 Hz), which means detected light generates 
an autocorrelation curve with sufficient SNR to assess tissue hemodynamics every 
second. Work completed in this thesis used few-mode fiber bundles for optimal temporal 
resolution of light detection (Dietsche et al., 2007). However for the adult head (Chapter 
4), long data acquisition times (~30-60 seconds) were acquired by ML DCS despite 
utilizing up to 10 few-mode detection fibers located at the largest source-detector 
distance. Future improvements to DCS techniques presented in this thesis would be to 
incorporate new innovative methods. For example, converting the correlator board from 
the computationally expensive hardware to software would improve the throughput up to 
50 Hz, which is fast enough to resolve heartbeat fluctuations (Wang et al., 2016). 
Implementing recent innovations with the ML DCS technique presented in Chapter 4 will 
increase the speed of blood flow measurements, which may provide real-time perfusion 
changes at the bedside of neurocritical adults. 
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5.2.3 Clinical Validation 
Pre-clinical experiments simplify optical data collection by lessening potential artifacts, 
such to hair and motion; however, in the clinic, these artifacts are difficult to avoid. 
Therefore, it is imperative to demonstrate and validate the feasibility of a NIRS/DCS 
system at the bedside of patients in clinical trials. 
Due to the challenges presented in the clinic, the accuracy and precision of ML 
DCS should be investigated and compared to various perfusion imaging modalities, 
including positron emission tomography, computed tomography, and magnetic resonance 
imaging (arterial spin labeling or phase-contrast). Next, different neurological 
emergencies should be assessed to investigate the clinical value of monitoring CBF with 
regards to improving the detection and prognosis of delayed cerebral ischemia. Lastly, a 
comparison of the success/failure of monitoring changes in CBF by ML DCS with 
different management strategies to current clinical care practices would determine the 
extent ML DCS fulfills a niche as a noninvasive bedside monitoring device of blood flow 
before accepting DCS as a useful bedside management tool in the ICU. The same extent 
of clinical trials should be performed to investigate the clinical utility of combining ML 
DCS and TR NIRS to quantify CMRO2. Clinical trials, in which, both CBF and CMRO2 
is monitored should be completed to understand the relationship during treatment of 
neurological emergencies in the ICU to optimize patient outcome.  
5.3 Conclusions 
With the purpose of assessing cerebral hemodynamics at the bedside, the primary 
findings of this thesis advanced DCS by: 
1. An all-optical modality, which included combining DCS and TR NIRS, 
demonstrated changes in absolute CMRO2 agree well with direct measurements of 
blood oxygenation in newborn pigs. 
2. Relative flow changes measured by DCS, which was confirmed by computed 
tomography, are similar when characterized by Brownian and hydrodynamic 
models directly on the exposed cortical tissue in pigs. Although the latter provides a 
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better fit to DCS data, the former is more robust deeming it the better model to 
characterize flow changes by DCS. 
3. Implementation of a multi-layered model to DCS separates flow in extracerebral 
and cerebral tissues successfully. Furthermore, the relative changes in CBF 
measured by a multi-layered DCS technique were in good agreement with 
perfusion changes measured by computed tomography in pigs, which had an 
extracerebral tissue thickness of 1 cm. 
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APPENDICES 
Appendix A: Animal Protocol Approval and Modifications 
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